Document:

IRREVOCABLE
MANAGEMENT TRUST AGREEMENT NUMBER F/2868 (TWO THOUSAND EIGHT HUNDRED SIXTY EIGHT) DATED MARCH 10, 2017 (THE “AGREEMENT”),
ENTERED INTO BY AND BETWEEN EACH OF MANUEL COSME ODABACHIAN AND CARLOS FERNANDO ALAMAN VOLNIE, IN THEIR CAPACITY AS TRUSTORS AND
BENEFICIARIES (COLLECTIVELY, “BENEFICIARY A”), ON THEIR OWN BEHALF; ONCBIOMUNE PHARMACEUTICALS, INC., IN ITS
CAPACITY AS TRUSTOR AND BENEFICIARY (“BENEFICIARY B”), REPRESENTED HEREIN BY ANDREW ALBERT KUCHARCHUK; AND
BANCO ACTINVER, S.A., INSTITUCIÓN DE BANCA MÚLTIPLE, GRUPO FINANCIERO ACTINVER, AS TRUSTEE (THE “TRUSTEE”),
REPRESENTED HEREIN BY ITS TRUST OFFICERS OSCAR MEJÍA REYES AND GABRIELA ALEJANDRA ESPÍNDOLA; PURSUANT TO THE FOLLOWING
REPRESENTATIONS AND CLAUSES:

 

Representations

 

I.
Each individual constituting Beneficiary A hereby represents, individually with respect to themselves, that:

 

	(a)	Each
    is an individual, resident of Mexico;
	 	 
	(b)	Each
    has full legal capacity and authority to enter into and comply with their obligations under this Agreement pursuant to its
    terms;
	 	 
	(c)	Entering
    into and performing under this Agreement does not entail a violation or breach of (i) any agreement, contract, license, resolution
    or order to which each is a party, or to which any of their assets is subject; or (ii) any law, regulation, circular letter,
    order or decree from any Governmental Authority applicable to each individual constituting Beneficiary A;
	 	 
	(d)	Each
    individual constituting Beneficiary A is the sole and exclusive owner of 49 shares, (together, a total of 98 shares of the
    fixed capital stock of Vitel) which together represent 98% of the outstanding capital stock of Vitel Laboratorios, S.A. de
    C.V. (“Vitel”), which are free from all liens, conditions, limitations or restrictions on ownership, or
    any option or preferential right of any kind, except for the restrictions set forth in the bylaws of Vitel and in the LGSM
    (as such term is defined below), which have been obtained from legal sources, as a result of activities performed within the
    framework of the law, and that there is no connection whatsoever to illegal activities;
	 	 
	(e)	Each
    individual constituting Beneficiary A wishes to transfer to the Trustee, and for the Trust Purposes, ownership of and title
    over his portion of the Vitel Shares (as such terms are defined below);
	 	 
	(f)	The
    49 shares of the capital stock of Vitel that each individual constituting Beneficiary A currently owns (together, a total
    of 98 shares of the fixed capital stock of Vitel) are not subject to any contract, agreement, or any other document that pursuant
    to its terms (i) creates a call option or purchase right, or any other right to acquire such shares, in favor of a third party;
    or (ii) restricts, in any way, any assignment, transfer, or pledge, except for the restrictions set forth in the bylaws of
    Vitel and in the LGSM;

 

    	 1

    	 	 	 

    

 

	(g)	Except
    for the authorizations that, as applicable, have been obtained and are in full force and effect, no authorization or approval
    whatsoever is required to enter into this Agreement, or to comply with or perform the obligations assumed by each individual
    constituting Beneficiary A in terms of this Agreement, which are legal, valid, binding, and enforceable against him pursuant
    to their respective terms;
	 	 
	(h)	As
    of this date there is no, and to the best of his knowledge there is no risk that any, action, complaint, claim, legal requirement,
    or proceeding will be filed before any court, governmental agency, arbitrator, or judicial body with regard to him or his
    property (i) that affects the legality, validity, or enforceability of this Agreement, (ii) the legal title over the Vitel
    Shares that each individual constituting Beneficiary A owns, or the transfer of the Vitel Shares to the Trustee in accordance
    with the terms of this Agreement, or (iii) that prevents the consummation of any of the transactions contemplated herein;
	 	 
	(i)	Each
    individual constituting Beneficiary A, and to the best of their knowledge, their agents are in compliance with the FCPA, or
    any other Anticorruption Law (as such terms are defined below) in force in the United States of America, and with any other
    Anticorruption Law in force in Mexico, and such individuals are not Blocked Persons. As of this date, each individual constituting
    Beneficiary A has not received any notice that any investigation has been initiated against him or, to the best of each individual
    constituting Beneficiary A’s knowledge, his agents, in connection with a violation of the FCPA, or any other Anticorruption
    Law;
	 	 
	(j)	Prior
    to executing this Agreement, the Trustee invited each individual constituting Beneficiary A to, and suggested that each, procure
    the services of a professional, firm, or company of his choice to provide him advice and support regarding the scope, consequences,
    processes, implications, and in general, legal and tax matters directly or indirectly associated with this Agreement, and
    his support in the negotiation and evaluation of the legal and tax risks associated with the final text to be executed, given
    that the Trustee waives any liability with regard to such matters; therefore, the Trustee does not warrant or assure that
    the tax structure provided in this Agreement will not be altered with subsequent amendments to the tax law, and the tax and
    assessment impacts may change;
	 	 
	(k)	By
    executing this Agreement, each individual constituting Beneficiary A expressly and irrevocably authorizes the Trustee, in
    terms of article 28 of the Law that Regulates Credit Information Companies (Ley para Regular las Sociedades de Información
    Crediticia), to perform, at their sole cost and expense, starting on the date of this Agreement, and at any subsequent
    time, and during the term of this Agreement, as many information requests as the Trustee may deem necessary from the credit
    information companies authorized to operate in Mexico;

 

    	 2

    	 	 	 

    

 

	(l)	The
    Trustee has clearly explained, leaving no room for doubt, the terms, meaning, and legal consequences of (i) article 106, XIX,
    b) of the LIC, and (ii) section 6 of Circular Letter 1/2005 issued by the Mexican Central Bank (Banco de México);
    
	 	 
	(m)	Pursuant
    to the second paragraph of article 80 of the LIC, and item 5 of Circular Letter 1/2005 issued by the Mexican Central Bank,
    each individual constituting Beneficiary A acknowledges that the Trustee shall be liable for the damages resulting from a
    breach by the Trustee of its obligations pursuant to this Agreement subject to the limitations set forth in Sections 11.1
    and 13.1 of this Agreement;
	 	 
	(n)	Each
    individual constituting Beneficiary A acknowledges and agrees that entering into this Trust Agreement requires them to provide
    to the Trustee, on an annual basis, an update of the information and documentation that the Trustee has requested from them,
    pursuant to the Know Your Customer Policies of the Trustee, in terms of the Nineteenth, Fortieth, Forty-First, and Forth Transitory
    general provisions referenced in the fourth paragraph of article One Hundred Fifteen of the LIC;
	 	 
	(o)	Each
    individual constituting Beneficiary A understands and agrees that, with the exception of the Shareholders’ Agreement
    (as such term is defined below) the Trustee does not know, nor is it required to know, the terms and conditions of such agreements
    associated with and derived from this Agreement, which have been entered into by and between the parties hereto without the
    participation of the Trustee; provided that the Trustee shall not be liable in any way regarding the veracity, legitimacy,
    authenticity, or legality of such agreements, and that the Trustee, unless it is a part thereof, and enters into them in compliance
    with instructions provided pursuant to this Trust Agreement, is not, and shall not be, bound in any way by such agreements,
    any other documents, and their respective exhibits. Likewise, each individual constituting Beneficiary A acknowledges that
    the liability regarding legitimacy, authenticity, and legality of the agreements mentioned in this paragraph, is directly
    and exclusively borne by the parties that execute them;
	 	 
	(p)	In
    terms of the provisions of article 17 of the Federal Law to Prevent and Identify Transactions with Resources from Illegal
    Sources (Ley Federal para la Prevención e Identificación de Operaciones con Recursos de Procedencia Ilícita),
    each individual constituting Beneficiary A hereby represents that he will not perform vulnerable transactions through this
    Trust Agreement;
	 	 
	(q)	The
    Trustee has made each Beneficiary A aware of its Privacy Policy, which refers to the document in physical, electronic or any
    other format generated by Banco Actinver, S.A., Institución de Banca Múltiple, Grupo Financiero Actinver, in
    its capacity as responsible party, which can be consulted in the webpage of Banco Actinver, S.A., Institución de Banca
    Múltiple, Grupo Financiero Actinver, in the following address http://www.actinver.com.mx, same which was made known
    to each Beneficiary A prior to handling their Personal Information as provided in the Federal Law for the Protection of Personal
    Information in Possession of Private Entities or Individuals (“LFPFP”), and that forms part of this Agreement;
    and

 

    	 3

    	 	 	 

    

 

	 	As
    provided in the LFPDP, the Beneficiaries A hereby grant Banco Actinver, S.A., Institución de Banca Múltiple,
    Grupo Financiero Actinver their express consent to handle their Personal Information by executing this Agreement, accepting
    the terms and conditions by which Banco Actinver, S.A., Institución de Banca Múltiple, Grupo Financiero Actinver
    will have the obligation to inform each Beneficiary A, through its Privacy Policies, the information it will be collecting
    and for what purpose. Likewise, the Beneficiaries A may request Banco Actinver, S.A., Institución de Banca Múltiple,
    Grupo Financiero Actinver, at any moment, to be given access, rectification, cancellation or opposition with respect of the
    Personal Information corresponding to each, through the format provided at Banco Actinver, S.A., Institución de Banca
    Múltiple, Grupo Financiero Actinver. Such format must contain and include the information and documentation mentioned
    in the Privacy Policy. Banco Actinver, S.A., Institución de Banca Múltiple, Grupo Financiero Actinver, shall
    communicate to each Beneficiary A, within a maximum term of 20 (twenty) business days as of the date in which such format
    was received, the determination which was reached, for purposes of, as applicable, such determination to enter into effect
    within the following 15 (fifteen) business days following the date in which such response was communicated. In connection
    with requests for access to Personal Information, the delivery shall take place prior delivery proof of the Beneficiary’s
    identity. The terms referred herein may be extended in one occasion for an equal amount of days, as long as the circumstances
    of each case justify such extension. Banco Actinver, S.A., Institución de Banca Múltiple, Grupo Financiero Actinver
    may deny Access to Personal Information, or carry out any rectification or cancellation, or grant the opposition for the treatment
    of information as provided in the LFPDP.
	 	 
	II.	Beneficiary
    B hereby represents, through its legal representative, that:
	 	 
	(a)	It
    is a corporation, duly organized and validly existing under the laws of the State of Nevada, USA;
	 	 
	(b)	It
    has full legal capacity and sufficient corporate authorizations to enter into and comply with its obligations under this Agreement
    pursuant to its terms;
	 	 
	(c)	Entering
    into and performing under this Agreement does not entail a violation or breach of (i) any provision of its corporate bylaws;
    or (ii) any agreement, contract, license, resolution or order to which it is a party, or to which Beneficiary B, or any of
    its assets is subject; or (iii) any law, regulation, circular letter, order or decree from any Governmental Authority applicable
    to Beneficiary B;
	 	 
	(d)	It
    has issued the OBM Shares (as such term is defined below) to the Trustee to hold in its capacity as trustee of this Trust
    Agreement, for the benefit of Beneficiary A, which shares are free from all liens, conditions, limitations or restrictions
    on ownership, or any option or preferential right of any kind, and which have been duly authorized, validly issued, fully
    paid and non-assessable, and that such issuance has no connection whatsoever to illegal activities; 

 

    	 4

    	 	 	 

    

 

	(e)	It
    wishes to transfer to the Trustee, and for the Trust Purposes, ownership of and title over the OBM Shares;
	 	 
	(f)	The
    OBM Shares are not subject to any contract, agreement, or any other document that pursuant to its terms (i) creates a call
    option or purchase right, or any other right to acquire such shares, in favor of a third party; or (ii) restricts, in any
    way, any assignment, transfer, or pledge, except for the restrictions set forth in the Shareholders Agreement;
	 	 
	(g)	Except
    for the authorizations that, as applicable, have been obtained and are in full force and effect, no authorization or approval
    whatsoever is required to enter into this Agreement, or to comply with or perform the obligations assumed by it in terms of
    this Agreement, which are legal, valid, binding, and enforceable against Beneficiary B pursuant to their respective terms;
	 	 
	(h)	As
    of this date there is no, and to the best of its knowledge there is no risk that any, action, complaint, claim, legal requirement,
    or proceeding will be filed before any court, governmental agency, arbitrator, or judicial body with regard to Beneficiary
    B or its property (i) that affects the legality, validity, or enforceability of this Agreement, (ii) the legal title over
    the OBM Shares or the transfer of the OBM Shares to the Trustee in accordance with the terms of this Agreement, or (iii) that
    prevents the consummation of any of the transactions contemplated herein;
	 	 
	(i)	Its
    representative has sufficient powers of attorney and authorities, and the corporate authorizations required to validly enter
    into this Agreement on its behalf, and to validly bind Beneficiary B under the terms hereof, and that such powers of attorney,
    authorities, and corporate or other authorizations have not been revoked, amended, or limited in any way;
	 	 
	(j)	To
    the best of its knowledge, Beneficiary B, and all its directors, officers, employees, and agents, including the OBM Principal
    Shareholders, are in compliance with the FCPA, or any other Anticorruption Law (as such terms are defined below) in force
    in the United States of America, and with any other Anticorruption Law in force in the jurisdiction in which it has been organized,
    and such individuals are not Blocked Persons. As of this date, it has not received any notice (to the best of Beneficiary
    B’s knowledge) that any investigation has been initiated against Beneficiary B, or its directors, officers, employees,
    and agents, including the OBM Principal Shareholders, in connection with a violation of the FCPA, or any other Anticorruption
    Law;
	 	 
	(k)	Prior
    to executing this Agreement, the Trustee invited it to, and suggested that it, procure the services of a professional, firm,
    or company of its choice to provide it advice and support regarding the scope, consequences, processes, implications, and
    in general, legal and tax matters directly or indirectly associated with this Agreement, and its support in the negotiation
    and evaluation of the legal and tax risks associated with the final text to be executed, given that the Trustee waives any
    liability with regard to such matters, therefore, the Trustee does not warrant or assure that the tax structure provided in
    this Agreement will not be altered with subsequent amendments to the tax law, and the tax and assessment impacts may change;

 

    	 5

    	 	 	 

    

 

	(l)	By
    executing this Agreement, it expressly and irrevocably authorizes the Trustee, in terms of article 28 of the Law that Regulates
    Credit Information Companies, to perform, at its exclusive cost and expense, starting on the date of this Agreement, and at
    any subsequent time, and during the term of this Agreement, as many information requests as it may deem necessary from the
    credit information companies authorized to operate in Mexico;
	 	 
	(m)	The
    Trustee has clearly explained, leaving no room for doubt, the terms, meaning, and legal consequences of (i) article 106, XIX,
    b) of the LIC, and (ii) section 6 of Circular Letter 1/2005 issued by the Mexican Central Bank;
	 	 
	(n)	Pursuant
    to the second paragraph of article 80 of the LIC, and item 5 of Circular Letter 1/2005 issued by the Mexican Central Bank,
    it acknowledges that the Trustee shall be liable for the damages resulting from a breach by the Trustee of its obligations
    pursuant to this Agreement subject to the limitations set forth in Sections 11.1 and 13.1 of this Agreement;
	 	 
	(o)	It
    acknowledges and agrees that entering into this Trust Agreement requires it to provide to the Trustee, on an annual basis,
    an update of the information and documentation that the Trustee has requested from it, pursuant to the Know Your Customer
    Policies of the Trustee, in terms of the Nineteenth, Fortieth, Forty-First, and Forth Transitory general provisions referenced
    in the fourth paragraph of article One Hundred Fifteen of the LIC;
	 	 
	(p)	It
    understands and agrees that, with the exception of the Shareholders’ Agreement, the Trustee does not know, nor is it
    required to know, the terms and conditions of such agreements associated with and derived from this Agreement, which have
    been entered into by and between the parties hereto without the participation of the Trustee; provided that the Trustee shall
    not be liable in any way regarding the veracity, legitimacy, authenticity, or legality of such agreements, and that the Trustee,
    unless it is a part thereof, and enters into them in compliance with instructions provided pursuant to this Trust Agreement,
    is not, and shall not be, bound in any way by such agreements, any other documents, and their respective exhibits. Likewise,
    it acknowledges that the liability regarding legitimacy, authenticity, and legality of the agreements mentioned in this paragraph,
    is directly and exclusively borne by the parties that execute them;
	 	 
	(q)	In
    terms of the provisions of article 17 of the Federal Law to Prevent and Identify Transactions with Resources from Illegal
    Sources, it hereby represents that it will not perform vulnerable transactions through this Trust Agreement; and

 

    	 6

    	 	 	 

    

 

	(r)	The
    Trustee has made Beneficiary B aware of its Privacy Policy, which refers to the document in physical, electronic or any other
    format generated by Banco Actinver, S.A., Institución de Banca Múltiple, Grupo Financiero Actinver, in its capacity
    as responsible party, which can be consulted in the webpage of Banco Actinver, S.A., Institución de Banca Múltiple,
    Grupo Financiero Actinver, in the following address http://www.actinver.com.mx, same which was made known to Beneficiary B
    prior to handling its Personal Information as provided in the Federal Law for the Protection of Personal Information in Possession
    of Private Entities or Individuals (“LFPFP”), and that forms part of this Agreement.
	 	 
	 	As
    provided in the LFPDP, Beneficiaries B hereby grants Banco Actinver, S.A., Institución de Banca Múltiple, Grupo
    Financiero Actinver its express consent to handle its Personal Information by executing this Agreement, accepting the terms
    and conditions by which Banco Actinver, S.A., Institución de Banca Múltiple, Grupo Financiero Actinver will
    have the obligation to inform Beneficiary B, through its Privacy Policies, the information it will be collecting and for what
    purpose. Likewise, Beneficiaries B may request Banco Actinver, S.A., Institución de Banca Múltiple, Grupo Financiero
    Actinver, at any moment, to be given access, rectification, cancellation or opposition with respect of its Personal Information,
    through the format provided at Banco Actinver, S.A., Institución de Banca Múltiple, Grupo Financiero Actinver.
    Such format must contain and include the information and documentation mentioned in the Privacy Policy. Banco Actinver, S.A.,
    Institución de Banca Múltiple, Grupo Financiero Actinver, shall communicate to Beneficiary B, within a maximum
    term of 20 (twenty) business days as of the date in which such format was received, the determination which was reached, for
    purposes of, as applicable, such determination to enter into effect within the following 15 (fifteen) business days following
    the date in which such response was communicated. In connection with requests for access to Personal Information, the delivery
    shall take place prior delivery proof of the Beneficiary’s identity. The terms referred herein may be extended in one
    occasion for an equal amount of days, as long as the circumstances of each case justify such extension. Banco Actinver, S.A.,
    Institución de Banca Múltiple, Grupo Financiero Actinver may deny Access to Personal Information, or carry out
    any rectification or cancellation, or grant the opposition for the treatment of information as provided in the LFPDP.
	 	 
	III.	The
    Trustee hereby represents, through its trust officer, that:
	 	 
	(a)	It
    is a multiple banking institution (institución de banca multiple), duly organized and validly existing under
    the laws of Mexico, and authorized to act as a trust company in the transactions referenced in article 46 (forty-six), section
    XV (roman numeral fifteen) of the LIC, as evidenced in public instrument number 35,694 dated March 1st, 2010, granted
    by Héctor Manuel Cárdenas Villarreal, Esq., Notary Public number 201 of the Federal District, which has been
    duly registered in the Public Registry of Commerce under commercial folio number 357980 on April 15, 2010;

 

    	 7

    	 	 	 

    

 

	(b)	It
    is its intent to enter into this Agreement, and accept its appointment as Trustee, and perform each and every one of the actions
    required, or deemed convenient, to satisfy and comply with the Trust Purposes, and to comply with its obligations pursuant
    to this Agreement and Applicable Law;
	 	 
	(c)	It
    does not require any authorization or approval to enter into this Agreement, or to comply with, or perform the obligations
    assumed by it in terms of this Agreement, which are legal, binding, and enforceable against the Trustee pursuant to their
    terms; and
	 	 
	(d)	Its
    trust officers evidence their legal capacity through public instrument 39,122 dated June 7, 2013 granted by José Luis
    Villavicencio Castañeda, Esq., Notary Public number 218 of Mexico City, whose first official transcript has been duly
    registered in the Public Registry of Commerce of Mexico City under commercial folio number 39338 on June 11, 2013 and public
    instrument 96,899, dated March 4, 2015, granted by Joaquin Talavera Sanchez, Esq., Notary Public number 40 of Mexico City,
    registered in the Public Registry of Commerce of Mexico City under the commercial folio number 357980 dated March 24, 2015;
    through which their appointment as trust officers, and the powers of attorney granted by the Trustee, were certified, and
    whose authorities and powers of attorney have not been revoked, amended, or limited in any way as of this date.

 

NOW
THEREFORE, based on the preceding Representations, the parties agree to the following Clauses:

 

CLAUSE
I: DEFINITIONS

 

Clause
1.1 Defined Terms. Capitalized terms used herein shall have the following meanings:

 

“Affiliate”
means, in connection with any Person (i) any other Person that, directly or indirectly, Controls, is Controlled by, or is under
common Control with, such Person, or (ii) any other Person that owns or controls 50% (fifty percent) or more of the shares or
membership interests issued, and with voting rights, of such Person, or (iii) any officer, managing member, executive, or manager
of such Person, or (iv) any other Person that is an officer, executive, managing member, manager, or holds 50% (fifty percent)
or more of the shares or membership interests with voting rights of any of the Persons mentioned in subsections (i) to (iii) of
this definition.

 

“Agreement”,
“Trust Agreement” or “Trust” means this Irrevocable Trust Agreement number F/2868 (two thousand
eight hundred sixty eight), as amended, whether in whole or in part, supplemented, or otherwise altered, renewed, or extended
at any time.

 

“Anticorruption
Law” means the FCPA in force in the United States of America, the Federal Anticorruption Law on Public Procurement Matters
(Ley Federal Anticorrupción en Contrataciones Públicas) in force in Mexico, and all other laws, regulations,
orders, and any other similar regulation associated with anticorruption laws, anti-boycott laws, fraud, gifts, bribery, anti-money
laundering, intended to control, prevent, or penalize bribery, gifts, illegal gratuities and benefits, or other similar illegal
practices.

 

    	 8

    	 	 	 

    

 

“Applicable
Law” means, with regard to any circumstance described in this Agreement, any laws, rules, regulations, codes, and other
general provisions applicable in Mexico to such circumstance, and the orders, decrees, rulings, court orders, notices or agreements
that are valid and in force, issued, enacted, or executed by any Governmental Authority that are applicable to such circumstance.

 

“Beneficiaries”
means, jointly, Beneficiary A, and Beneficiary B.

 

“Beneficiary
A” has the meaning given to such term in the preamble of this Agreement.

 

“Beneficiary
B” has the meaning given to such term in the preamble of this Agreement.

 

“Beneficiary
Rights” means the rights to which the Beneficiaries of this Agreement are entitled, respectively, pursuant to their
capacity as beneficiaries, and in connection with their respective interest in the Trust Property.

 

“Blocked
Person” means any Person:

 

(i)
that is included in the Annex, or otherwise subject to the provisions of Executive Order No. 13224 on Terrorist Financing, effective
September 24, 2001, and relating to Blocking Property and Prohibiting Transactions With Persons Who Commit, Threaten to Commit,
or Support Terrorism (the “Executive Order”), or a person who is identified as an affiliate of a Person designated
as a terrorist, or associated with terrorism or money laundering pursuant to the regulations enacted in connection with the USA
PATRIOT ACT;

 

(ii)
that is owned or Controlled by, or acts on behalf of, any Person included in the Annex, or otherwise subject to, the Executive
Order;

 

(iii)
with whom a lender subject to oversight by financial authorities is prohibited from dealing or otherwise engaging in any transaction
by any terrorism of money laundering law, including the Executive Order;

 

(iv)
who commits, threatens, or conspires to commit or supports “terrorism”, as such term is defined in the Executive Order;

 

(v)
is a person designated as a “specially designated national and blocked person”, pursuant to the most recent list published
by the Office of Foreign Assets Control of the Treasury Department of the United States of America (“OFAC”),
in its official website, http://www.treas.gov.ofac/tllsdn.pdf, or any replacement website or other replacement official
publication of such list;

 

(vi)
who is not in compliance with OFAC, or the USA PATRIOT ACT; or

 

    	 9

    	 	 	 

    

 

(vii)
who is an Affiliate of any of the aforementioned Persons.

 

“Business
Day” means any day on which banks are not authorized to close in Mexico City.

 

“Control”
means the authority to determine the management, and the policies of a Person, directly or indirectly, whether through holding
securities or membership interests with voting rights, through an agreement, or otherwise.

 

“Distributions”
means, jointly, the OBM Distributions, and the Vitel Distributions.

 

“Dollars”
means the legal currency of the United States of America.

 

“FCPA”
means the Foreign Corrupt Practices Act of 1977 in force in the United States of America.

 

“Governmental
Authority” means any Federal, State, Municipal, or local authority in the United States of America or Mexico.

 

“Initial
Contribution” means the amount of 1,000.00 (one thousand 00/100 pesos), which the Beneficiaries shall provide jointly
to the Trustee in terms of Clause 2.1(b) of this Agreement.

 

“LGSM”
means the General Law of Companies (Ley General de Sociedades Mercantiles), as amended, or supplemented from time to time.

 

“LGTOC”
means the General Law of Negotiable Instruments and Credit Transactions (Ley General de Títulos y Operaciones de Crédito),
as amended, or supplemented from time to time.

 

“LIC”
means the Credit Institutions Law (Ley de Instituciones de Crédito), as amended, or supplemented from time to time.

 

“Mexico”
means the United Mexican States.

 

“Minimum
Price” has the meaning given to such term in Clause 4.1(b)(i) of this Agreement.

 

“Notice
of Exercise” has the meaning given to such term in Clause 4.1(b)(ii) of this Agreement.

 

“Notice
of Offer” has the meaning given to such term in Clause 4.1(b)(i) of this Agreement.

 

“OBM”
means Oncbiomune Pharmaceuticals, Inc., a Nevada corporation.

 

    	 10

    	 	 	 

    

 

“OBM
Accounts” means the accounts denominated in Pesos or in Dollars, opened and kept at Banco Actinver, S.A., or at any
of the companies belonging to Grupo Financiero Actinver, under the name of the Trustee, for the purposes set forth in Clause
6.1(c) of this Agreement.

 

“OBM
Distributions” means the amounts that OBM distributes to its shareholders as dividends, equity reimbursements, or otherwise.

 

“OBM
Principal Shareholders” means Jonathan F. Head, Ph.D. and Andrew Albert Kucharchuk.

 

“OBM
Shares” means 61,158,013 (sixty one million one hundred fifty eight thousand thirteen) shares of common stock, and 2,107,681
(two million one hundred seven thousand six hundred eighty one) shares of Series B preferred stock, of OBM.

 

“Offered
Beneficiary Rights” has the meaning given to such term in Clause 4.1(b)(i) of this Agreement.

 

“Permitted
Investment” has the meaning given to such term in Clause 6.2(a) of this Agreement.

 

“Permitted
Transfer” means a transfer to a Permitted Transferee, pursuant to Clause IV of this Agreement.

 

“Permitted
Transferees” has the meaning given to such term in Clause 4.1(a) of this Agreement.

 

“Person”
means any natural or legal person, trust, joint venture, partnership or company, Governmental Authority, or any other entity of
any kind, with or without its own legal capacity.

 

“Pesos”
means the legal currency of Mexico.

 

“Right
of First Refusal” has the meaning given to such term in Clause 4.1(b) of this Agreement.

 

“ROFR
Deposit” has the meaning given to such term in Clause 4.1(b)(iii) of this Agreement.

 

“ROFR
Exercise Period” has the meaning given to such term in Clause 4.1(b)(ii) of this Agreement.

 

“Shareholders’
Agreement” means the Shareholders Agreement of OBM dated as of the date hereof among Beneficiary A, Beneficiary B and
the shareholders named therein, as amended, whether in whole or in part, supplemented, or otherwise altered, renewed, or extended
at any time, which will be part of this Agreement as Exhibit “A”.

 

“Taxes”
has the meaning given to such term in Clause 10.1 of this Agreement.

 

    	 11

    	 	 	 

    

 

“Term
of the Trust” means the period of validity and enforceability of this Trust Agreement as specified in Clause 12.2
of this Agreement.

 

“Third
Party Purchaser” has the meaning given to such term in Clause 4.1(b)(i) of this Agreement.

 

“Third
Party Sale Agreement” has the meaning given to such term in Clause 4.1(b)(vi) of this Agreement.

 

“Transfer”
shall mean, with respect to any Beneficiary Rights, (i) when used as a verb, to sell, assign, dispose of, exchange, pledge, charge,
encumber, hypothecate or otherwise transfer such Beneficiary Rights or any participation or interest therein, whether directly
or indirectly (including by means of any hedging or derivative transactions that may have a similar effect to the foregoing),
or agree or commit to do any of the foregoing; and (ii) when used as a noun, a direct or indirect sale, assignment, disposition,
exchange, pledge, charge, encumbrance, hypothecation, or other transfer of such Beneficiary Rights or any participation or interest
therein (or any hedging or derivative transactions that may have a similar effect to the foregoing) or any agreement or commitment
to do any of the foregoing.

 

“Trust
Accounts” means jointly, the OBM Accounts and the Vitel Accounts.

 

“Trust
Property” has the meaning given to such term in Clause 2.2 of this Agreement.

 

“Trust
Purposes” has the meaning given to such term in Clause 2.4 of this Agreement.

 

“Trustee”
has the meaning given to such term in the preamble of this Agreement.

 

“Vitel
Accounts” means the accounts denominated in Pesos or in Dollars, opened and kept at Banco Actinver, S.A., or at any
of the companies belonging to Grupo Financiero Actinver, under the name of the Trustee, for the purposes set forth in Clause
6.1(c) of this Agreement.

 

“Vitel
Distributions” means the amounts that Vitel distributes to its shareholders as dividends, equity reimbursements, or
otherwise.

 

“Vitel
Shares” means 100 (one hundred) shares of the fixed capital stock of Vitel, representing 100% (one hundred per cent)
of the capital stock of Vitel, less two shares of the capital stock of Vitel, property of OBM.

 

Clause
1.2 Interpretation of Defined Terms. The definitions set forth in the preceding Clause shall apply both in the singular
and plural form of such terms. When the context requires it, any pronoun shall include the corresponding male, female, and neutral
form. Unless the context requires otherwise, all references to clauses, paragraphs, subsections, items, or numbers of clauses
of this Agreement, and all references to schedules and exhibits, shall be deemed to be references to schedules and exhibits to
this Agreement, which are hereby incorporated by reference to form an integral part of this Agreement. Unless the context requires
otherwise, the words (a) “hereof”, “herein”, “hereunder”, “pursuant
hereto”, “below”, and words with similar meaning when used in this Agreement, shall be deemed to
refer to this Agreement in its entirety, and not to any specific clause, paragraph, subsection, item, or number of this Agreement;
(b) “include”, “includes”, and “including” shall be deemed followed by
the phrase, “but not limited to”, unless otherwise specified; and (c) “asset”, or “property”
shall be deemed to have the meaning and effect, and to refer to, each and every one of the assets and property, whether tangible
or intangible, including cash, shares, or interests, representing the capital stock of any company or Person, securities, income,
lease and contractual rights. Likewise, references to (i) any agreement, contract, document, or instrument, includes the reference
to such agreement, contract, document, or instrument, as amended, whether in whole or in part, supplemented, or otherwise altered
from time to time, and (ii) any law, rule, or regulation, includes the amendments thereto from time to time, or any law, rule,
or regulation that replaces them.

 

    	 12

    	 	 	 

    

CLAUSE
II: THE TRUST

 

Clause
2.1 Creation of the Trust; Acceptance of the Appointment of the Trustee and Term.

 

(a)
Creation of the Trust. Manuel Cosme Odabachian and Carlos Fernando Alaman Volnie hereby agree to contribute, assign, and
transfer to the Trustee, ownership of, and title over, the Vitel Shares, within the following 5 (five) Business Days as of the
date hereof. Oncbiomune Pharmaceuticals, Inc. hereby agrees to contribute, assign, and transfer to the Trustee, ownership of,
and title over, the OBM Shares, within the following 5 (five) Business Days as of the date hereof. The Beneficiaries jointly settle
the Administration and Stock Control Trust Agreement with Banco Actinver, S.A., Institución de Banca Múltiple, Grupo
Financiero Actinver, as trustee of the present Trust Agreement, in order to be the owner and proprietor of the Trust Property,
in furtherance of the Trust Purposes, as provided herein and in the Applicable Law. Likewise, the Beneficiaries jointly as a single
beneficiary, and in equal portions (50% Beneficiary A and 50% Beneficiary B), hereby provide the Initial Contribution to the Trustee.

 

(b)
Delivery of Shares to the Trustee. The parties agree to deliver the Vitel Shares and the OBM Shares, as applicable, as
follows within the following 5 (five) Business Days as of the date hereof:

 

	 	(i)	In
    connection with the Vitel Shares, the Beneficiaries A shall deliver to the Trustee the Vitel Shares, duly endorsed in favor
    of the Trustee, and shall cause the Secretary of the Board of Vitel to issue an acknowledgement of such transfer and certifying
    that the Trustee is registered with Vitel as one of its shareholders; and 
	 	 	 
	 	(ii)	In
    connection with the OBM Shares, the Beneficiary B shall deliver to the Trustee the newly issued OBM Shares, issued in favor
    of the Trustee, and shall cause the appropriate official of OBM to issue an acknowledgement of such transfer and certifying
    that the Trustee is registered with OBM as one of its shareholders. 

 

    	 13

    	 	 	 

    

 

(c)
Acceptance of the Appointment of the Trustee. The Trustee hereby (a) accepts its appointment as Trustee of this Agreement,
and agrees to duly and faithfully comply with the Trust Purposes, and with all obligations assumed by the Trustee in terms of
this Agreement, and Applicable Law; (ii) receives the Initial Contribution pursuant to the terms of this Agreement; and (iii)
acknowledges and accepts title over the Trust Property that is transferred to the Trustee for the Trust Purposes. The Trustee
is hereby authorized to perform all actions required to comply with the Trust Purposes, and it hereby agrees to perform any actions
required or convenient to comply with the Trust Purposes.

 

Clause
2.2 Trust Purposes.

 

During
the term of this Agreement, the trust property is hereby formed, and shall be composed of, as applicable, the following assets
(jointly, the “Trust Property”):

 

(a)
the Initial Contribution;

 

(b)
the Vitel Shares;

 

(c)
the OBM Shares;

 

(d)
any amounts and other assets, property, or rights that the Trustee receives pursuant to having title over the Vitel Shares, and
the OBM Shares;

 

(e)
each and every amount deposited in the Trust Accounts;

 

(f)
each and every amount resulting from the Permitted Investments;

 

(g)
each and all property assigned to, or acquired by, the Trustee pursuant to the Trust Purposes as provided herein; and

 

(h)
all cash amounts, and all ancillary property, proceeds, products, and returns resulting from, or associated with, the property
described in the preceding subsections of this Clause, including the rights resulting from, or associated with, the investments
and operation of the Trust.

 

In
order to formalize the transfer of the OBM Shares and the Vitel Shares, the trustors, within five (5) days of the date hereof,
will (i) deliver to the Trustee the stock certificates which represent that shares which they own, duly endorsed in favor of the
Trustee, and (ii) deliver to the Trustee a certification issued by the Secretary of the Board of Directors which confirms that
the transfer of shares referred to in this Trust Agreement has been duly registered in the corresponding Shareholder’s Registry
Book of each entity.

 

For
the avoidance of doubt, the parties agree that the OBM Shares and the Vitel Shares shall be endorsed in favor of the Trustee bearing
the following legend, and including the place and date in which the endorsement took place, as well as the name or denomination
of the endorsing trustor:

 

    	 14

    	 	 	 

    

 

“The
undersigned endorses property of the present stock certificate and the shares it covers, in favor of Banco Actinver, S.A., Institución
de Banca Múltiple, Grupo Financiero Actinver,, in its capacity as Trustee of the Administration and Stock Control Trust
Agreement No. F/2686 (two thousand eight hundred sixty eight), in furtherance of the purposes set forth therein”.

 

The
parties hereby agree that the provisions of this Clause shall act as an inventory of the property that comprises the Trust Property
upon the creation of the Trust, and the execution of this Agreement, and the Beneficiaries shall keep a copy hereof, which they
receive from the Trustee to their full satisfaction. The foregoing in compliance with the provisions of item five point one of
Circular Letter 1/2005 (one slash two thousand five) issued by the Mexican Central Bank.

 

Clause
2.3 Parties to the Trust. The parties to this Agreement are the following:

 

MANUEL
COSME ODABACHIAN and CARLOS FERNANDO ALAMAN VOLNIE, jointly, in their capacity as Trustors and Beneficiaries A.

 

ONCBIOMUNE
PHARMACEUTICALS, INC. in its capacity as Trustor and Beneficiary B.

 

Banco
Actinver, S.A., Institución de Banca Múltiple, Grupo Financiero Actinver, in its capacity as Trustee.

 

Clause
2.4 Trust Purposes. The purposes of this Irrevocable Management Trust Agreement (the “Trust Purposes”)
are that the Trustee perform each and every one of the activities, and that it complies with each and every one of the obligations
described in this Clause 2.4, and in this Agreement, including (i) receiving the Initial Contribution, the Vitel Shares,
and the OBM Shares, and exercise, under instructions from the Beneficiary A, and Beneficiary B, as applicable, the corporate and
property rights and obligations resulting from holding the Vitel Shares, and the OBM Shares, respectively, in terms of this Agreement
and in compliance with the Shareholders Agreement; (ii) manage the Trust Property pursuant to the provisions of this Agreement;
(iii) provide to the Beneficiaries the Distributions that it receives as a result holding the Vitel Shares and the OBM Shares,
respectively, in terms of this Agreement; and (iv) perform all such activities that the Beneficiaries, as applicable, instruct
the Trustee in writing, which are specific for the activities described in this Clause. In connection with the foregoing, the
Trustee shall:

 

(a)
be the sole and legitimate owner, maintain and preserve ownership of the property and rights that, currently, or in the future,
form part of the Trust Property during the term of this Agreement;

 

    	 15

    	 	 	 

    

 

(b)
establish, maintain, and manage the Trust Accounts to adequately manage the funds that form part of the Trust Property, pursuant
to the provisions of this Agreement, and apply all funds to the Trust Accounts (including the Permitted Investments) pursuant
to this Agreement;

 

(c)
receive from Beneficiary A fiduciary ownership of, and title over, the Vitel Shares;

 

(d)
receive from Beneficiary B fiduciary ownership of, and title over, the OBM Shares;

 

(e)
exercise the corporate and property rights resulting from the Vitel Shares and the OBM Shares, pursuant to the provisions of this
Agreement and the Shareholders Agreement;

 

(f)
receive from Vitel and OBM amounts from dividends, equity reimbursements, or that are otherwise distributed in alignment to any
legal requirement, respectively, to their shareholders;

 

(g)
provide to the Beneficiaries the Distributions that it receives from Vitel and OBM, respectively, pursuant to the provisions of
this Agreement;

 

(h)
dispose of the Vitel Shares in terms of written instructions it receives from Beneficiary A in terms of this Agreement;

 

(i)
dispose of the OBM Shares in terms of written instructions it receives from Beneficiary B in terms of this Agreement;

 

(j)
pursuant to the written instructions from the Beneficiaries, invest any amounts deposited into the Trust Account in Permitted
Investments pursuant to the provisions of Clause 6.2 of this Agreement;

 

(k)
grant the general or special powers of attorney for acts of ownership, administration, litigation and collection, subscription
of negotiable instruments, and any other that is necessary or convenient to achieve the Trust Purposes, including those required
to defend the Trust Property, in favor of the Persons that the Beneficiaries instruct it in writing, as applicable, without this
including the authority for the appointed attorneys-in-fact to be able to open and operate bank accounts. The foregoing, provided
that the Trustee shall not grant general powers of attorney for acts of ownership, or general powers of attorney to subscribe,
guarantee, or endorse negotiable instruments in terms of article 9 of the LGTOC;

 

(k)
in general, perform any other action required or convenient to satisfy or comply with the Trust Purposes, or Applicable Law; and

 

(l)
return the Trust Property to the Beneficiaries pursuant to the provisions of Clause 10.2 of this Agreement.

 

    	 16

    	 	 	 

    

 

Clause
2.5 The Trustee.

 

(a)
Authorities of the Trustee. The Trustee shall have all authorities and powers of attorney required to comply with the Trust
Purposes, pursuant to the terms of Article 391 of the LGTOC; provided that the Trustee shall act at all times pursuant to the
instructions of the Beneficiaries.

 

(b)
Terms and Conditions of the Trustee’s Services. The Beneficiaries hereby expressly agree that the Trustee shall act
at all times pursuant to the provisions of this Agreement, in compliance with the obligations, and exercising the authorities
granted to it herein, for the purpose of complying with the Trust Purposes. Likewise, the Trustee shall act pursuant to the instructions
it receives in writing from the Beneficiaries, pursuant to the provisions of this Agreement. The Trustee shall not be liable for
(1) any actions it performs pursuant to the express provisions of this Agreement, (2) any actions it performs pursuant to the
express provisions of any other agreements or documents entered into or granted pursuant to what is expressly set forth herein,
including the Shareholders Agreement, (3) any actions that it performs pursuant to written instructions from the Beneficiaries,
pursuant to what is expressly set forth in this Agreement, (4) any representation made by the other parties to this Agreement,
(5) any delinquency or default regarding any payment, except for cases in which the delinquency or default results from a breach
by the Trustee of the obligations set forth in this Agreement, and (6) any event, action, or failure to act by the Beneficiaries,
or third parties, which prevent or hinder compliance with the Trust Purposes, unless the Trustee incurs willful misconduct, bad
faith, or negligence.

 

(c)
Non-Contemplated Situations. To the extent that a specific situation is not contemplated by the provisions of this Agreement,
the Trustee shall give notice to the Beneficiaries of such situation for the purpose that the Beneficiaries, as applicable, issue
the pertinent instructions based on which the Trustee shall act, provided the instructions from the Beneficiaries are grounded
on express authorities of such body, and the actions of the Trustee, resulting from such instructions, are grounded on specific
and legal purposes.

 

(d)
General Liability. Pursuant to rule 5.2 of Circular Letter 1/2005, issued by the Mexican Central Bank, the Trustee shall
have general liability for the damages caused as a result of its breach of its obligations pursuant to this Agreement subject
to the limitations set forth in Sections 11.1 and 13.2.

 

(e)
Removal of the Trustee. The Trustee may be removed at any time through written notice provided by both Beneficiaries (all
Beneficiary A and Beneficiary B, jointly) at least 30 (thirty) calendar days in advance. The Trustee may be removed with cause,
at the discretion of the Beneficiaries, at any time.

 

(f)
Resignation by the Trustee. The Trustee may only resign from its appointment if the circumstances set forth in article
391 of the LGTOC occur; provided that the Trustee shall give written notice to the Beneficiaries of its intent to resign its position,
at least 30 (thirty) calendar days in advance of the resignation date; and provided, further, that the Trustee shall not be released
as trustee of this Agreement, until a replacement trustee has been appointed by both Beneficiaries and such replacement trustee
has accepted its appointment in writing.

 

    	 17

    	 	 	 

    

 

(g)
Trustee Fees. As consideration for its trustee services under this Agreement, the Trustee shall have the right to receive
from the Beneficiaries the fees set forth below, which shall be paid by the Beneficiaries in equal parts (50% from Beneficiary
A and 50% from Beneficiary B):

 

	 	1.	For
    the review and drafting of the trust agreement, as well as for the acceptance of the appointment as Trustee, the amount of
    $40,000.00 (forty thousand pesos 00/100 M.N.) that the Trustors will pay in a single payment at the execution of the agreement.
	 	 	 
	 	2.	For
    the annual management of the Trust, the amount of $100,000.00 M.N. (one hundred thousand pesos 00/100 M.N.), which will be
    charged biannually in advance in an amount of $50,000.00 M.N. (fifty thousand pesos 00/100 M.N.) biannually.
	 	 	 
	 	3.	For
    each Amendment Agreement, the amount of $20,000.00 (twenty thousand pesos 00/100 M.N.) upon execution of the corresponding
    agreement.
	 	 	 
	 	4.	For
    the execution or appearance of the Trustee to any legal act other than the ones mentioned above, which may include: granting
    of powers-of-attorney; execution of public deeds, contracts or agreements, the amount of $ 4,000.00 (four thousand pesos 00/100
    M.N.) to be paid by the Trustors upon execution of the corresponding act, as required.

 

For
the transfer of funds via SPEI (Interbank Electronic Payments System) to main national banks, as long as such transactions are
carried out in Mexican pesos, as well as for the opening of the necessary subaccounts for the control and management of the estate,
the Trustee shall charge no fee.

 

For
the termination of the Trust, the Trustee shall charge no fee.

 

Any
other expenses incurred by the Trustee as a consequence of the management of the Trust, that could consist in reasonable fees
for lawyers, notaries, auditors, tax specialists and /or any other necessary expense, will be charged to the amount that each
one of them derives in its corresponding moment, prior to the acceptance of the Trustors.

 

The
fees set forth herein do not include the Value Added Tax (IVA), which shall be charged in accordance with the applicable laws.
Such trustee fees can be annually increased based on the variations of the National Consumer Price Index (Indice Nacional de
Precios al Consumidor) published by the Bank of Mexico (Banco de México) or its substitute.

 

In
case that the Trustee does not receive its corresponding fees in accordance with the present Clause, the Trustors will have to
pay monthly default interests for the amount resulting from adding the 28-day Interbank Equilibrium Interest Rate (Tasa de
Interés Interbancaria de Equilibrio a 28 días) (as published by the Bank of Mexico) on the day when the default
was incurred, plus 200 base points. The resulting amount will be the payable annual rate of default interest; said annual rate
will be charged for all the period in which the debt remains unpaid.

 

    	 18

    	 	 	 

    

 

The
default interests set forth in the present clause will be charged automatically with charge to the available liquid resources
in the Trust Assets, in case such funds are insufficient; the Trustors will cover the remaining amounts. The Parties expressly
agree that the estate of the present Trust preferably guarantees the payment of the Trustee’s fees. The Trustors, by executing
the present Agreement, expressly authorize the Trustee to avoid carrying out any legal act until its corresponding fees have been
completely covered, in case of a default in the payment of the Trustee’s fees.

 

The
default interests set forth in the present clause does not include Value Added Tax (IVA), which shall be charged in accordance
with the applicable laws.

 

If
the fees that the Trustee is entitled to receive are not covered, the Trustee may resign its appointment without prejudice to
the right to exercise legal actions for the collection of said fees.

 

The
Trustee shall abstain from carrying out any administrative procedure, as well as proceed to cancel this Trust as long as there
is any debt in favor of the Trust that is pending settlement.

 

CLAUSE
III: EXERCISE OF PROPERTY AND 

CORPORATE
RIGHTS OF VITEL AND OBM

 

Clause
3.1 Property Rights.

 

(a)
Vitel Shares. The property rights resulting from the Vitel Shares contributed to the Trust Property shall be exercised
by the Trustee exclusively for the benefit, and in terms of, the written instructions it receives from Beneficiary B. Beneficiary
B shall receive the amounts corresponding to dividends, equity reimbursements, or for any other concept that Vitel distributes
to its shareholders (the “Vitel Distributions”). The Vitel Distributions shall be received by the Trustee in
the Trust Account, and it shall provide them to Beneficiary B pursuant to the provisions of Clause VII of this Agreement.

 

(b)
OBM Shares. The property rights resulting from the OBM Shares contributed to the Trust Property shall be exercised by the
Trustee exclusively for the benefit, and in terms of, the written instructions it receives from Beneficiary A. Beneficiary A shall
receive the amounts corresponding to dividends, equity reimbursements, or for any other concept that OBM distributes to its shareholders
(the “OBM Distributions”). The OBM Distributions shall be received by the Trustee in the Trust Account, and
it shall provide them to Beneficiary A pursuant to the provisions of Clause VII of this Agreement.

 

    	 19

    	 	 	 

    

 

Clause
3.2 Corporate Rights.

 

(a)
Vitel Shares. The corporate rights resulting from the Vitel Shares shall be exercised by the Trustee pursuant to the written
instructions it receives from Beneficiary B. For such purposes, and pursuant to the bylaws of Vitel, Beneficiary B shall have
the authority to instruct the Trustee regarding exercising any corporate rights it may be entitled to in its capacity as the majority
Vitel shareholder, including, but not limited to, calling shareholder meetings, voting the Vitel Shares pursuant to the instructions
given by Beneficiary B, executing unanimous written consents in lieu of a meeting, adopting resolutions agreeing to pay the Vitel
Distributions and, in general, resolve any and all matters associated with Vitel, and exercising any other right it may be entitled
to in its capacity as the majority Vitel shareholder, pursuant to the provisions of this Agreement, the Vitel bylaws, and Applicable
Law.

 

(b)
OBM Shares. The corporate rights resulting from the OBM Shares shall be exercised by the Trustee pursuant to the written
instructions it receives from Beneficiary A. For such purposes, and pursuant to the bylaws of OBM, Beneficiary A shall have the
authority to instruct the Trustee regarding exercising any corporate rights it may be entitled to in its capacity as an OBM shareholder,
including, but not limited to, calling special shareholder meetings, voting the OBM Shares pursuant to the instructions given
by the Beneficiary A, executing unanimous written consents in lieu of a meeting, adopting resolutions agreeing to pay the OBM
Distributions and, in general, resolve any and all matters associated with OBM, and exercising any other right it may be entitled
to in its capacity as an OBM shareholder, pursuant to the provisions of this Agreement, the OBM bylaws, the Shareholders Agreement,
United States of America Securities Law and Applicable Law.

 

(c)
Powers of Attorney. The Trustee shall issue the certificates and documents, and shall grant the necessary powers of attorney
to the Person(s) designated in writing by Beneficiary A, and Beneficiary B, as applicable, provided (i) the written request is
provided to it at least 3 (three) Business Days in advance; and (ii) the relevant costs are paid by Beneficiary A, and Beneficiary
B, as applicable.

 

CLAUSE
IV: TRANSFER OF BENEFICIARY RIGHTS

 

Clause
4.1 Transfer of Beneficiary Rights.

 

(a)
Permitted Transfers.

 

(i)
Notwithstanding anything to the contrary in this Agreement, the Beneficiaries, acting individually, may at any time, without being
subject to Clause 4.1, Transfer their respective Beneficiary Rights (x) to any of their Affiliates (the “Permitted Transferees”),
or (y) with the prior consent of the other Beneficiary to this Agreement, or (z) as otherwise permitted under this Agreement (each,
a “Permitted Transfer”), in the understanding that (1) each Beneficiary A will be considered a Permitted
Transferee with respect to each other, (2) transfers by either of the Beneficiaries A resulting from their death shall also be
considered a Permitted Transfer, and (3) either of the Beneficiaries A may act individually in regards to this Clause.

 

    	 20

    	 	 	 

    

 

(ii)
If a Permitted Transferee ceases to be an Affiliate of the Beneficiary who Transferred Beneficiary Rights to such Permitted Transferee,
the Beneficiary Rights shall automatically revert or otherwise be transferred back to the original Beneficiary. The agreement
or other instrument pursuant to which a Beneficiary carries out a Permitted Transfer must specifically contain a provision expressly
contemplating the reversion of Beneficiary Rights or unwinding of the Permitted Transfer should the transferee cease to be a Permitted
Transferee at any time after the corresponding Transfer. If according to the applicable law such reversion is not permitted or
the transferring Beneficiary does not accept such reversion, then the non-transferring Beneficiary of this Agreement shall be
entitled to, provided that the transferring Beneficiary is bound to take any action that may be required from its part: (x) acquire
directly or through an Affiliate, the totality of the Beneficiary Rights of the Permitted Transferee that ceased to be an Affiliate,
(y) to request OBM or Vitel, as applicable, to carry out a capital reduction in order to redeem the shares which correspond to
the Beneficiary Rights of the Permitted Transferee that ceased to be an Affiliate, and to cause the corresponding Affiliate to
approve and participate in such reduction in accordance with applicable law, or (z) a combination of the rights set forth in (x)
and (y) of this subsection (ii). In the event that more than one non-transferring Beneficiary exercises its right to acquire the
Beneficiary Rights of the Permitted Transferee that ceased to be an Affiliate, the Beneficiaries who have exercised such right
to purchase the Beneficiary Rights of the Permitted Transferee that ceased to be an Affiliate shall be entitled and obligated
to purchase the entirety of such Beneficiary Rights in proportion to their holdings of Beneficiary Rights derived from this Trust
vis a vis the other Beneficiaries who have also exercised such right to purchase such Beneficiary Rights. The agreement
or other instrument pursuant to which a Beneficiary carries out a Permitted Transfer must specifically contain a provision expressly
granting such rights to the non-transferring Beneficiary.

 

(iii)
Each Beneficiary shall previously notify in writing the other Beneficiary and OBM or Vitel, as applicable, of any Permitted Transfer.

 

(iv)
Notwithstanding anything to the contrary in this clause, Beneficiary A may only carry out Permitted Transfers after 3 (three)
years from the execution of this Trust Agreement and any Permitted Transfer by Beneficiary A shall be made only to Mexican Affiliates.

 

(v)
Any attempted Transfer in violation of the terms of this Agreement, shall be deemed null and void and the Trustee shall refuse
to document or recognize such transfer in its record of Beneficiary Rights.

 

(b)
Right of First Refusal. Subject to the following: (1) the provisions of this Clause IV (particularly the provisions included
Clause 4.1(a)), and (2) upon Beneficiary B deregistering all its securities with the Securities and Exchange Commission of the
United States of America; in the event a Beneficiary wishes to sell, dispose of, transfer or assign its Beneficiary Rights, the
other Beneficiary shall have the irrevocable right of first refusal (“Right of First Refusal”), pursuant to
the following terms and conditions:

 

    	 21

    	 	 	 

    

 

(i)
Notice of Offer. In the event a Beneficiary, directly or indirectly, at any time, wishes or has the intention to Transfer
any of its Beneficiary Rights to a third party other than an Affiliate, such Beneficiary must deliver written notice of such intention
to the other Beneficiary and to the Trustee, with a copy to the Company (the “Notice of Offer”), indicating
(1) the percentage of Beneficiary Rights owned by the Beneficiary that are subject to such Transfer (the “Offered Beneficiary
Rights”), (2) the purchase price (the “Minimum Price”) for such Offered Beneficiary Rights, (3) all
other material terms and conditions of the proposed Transfer, including payment terms and the identity of the potential third
party purchaser (the “Third Party Purchaser”) with sufficient detail and (4) the terms and conditions contained
in the Notice of Offer shall be maintained for a transfer to the other Beneficiary in the event of a Notice of Exercise (as described
below).

 

(ii)
ROFR Exercise Period. The non-transferring Beneficiary, within thirty (30) calendar days after the receipt of the Notice
of Offer (the “ROFR Exercise Period”), may choose to either (i) purchase the Offered Beneficiary Rights or
(ii) not respond to the Notice of Offer. In the event a non-transferring Beneficiary wishes to purchase the Offered Beneficiary
Rights, it must exercise its Right of First Refusal by written notice (“Notice of Exercise”) given to the transferring
Beneficiary of its intent to purchase all, and not less than all, of the Offered Beneficiary Rights on the terms contained in
the Notice of Offer, at the proposed Minimum Price. In the event that more than one non-transferring Beneficiary exercises its
right to acquire the Offered Beneficiary Rights, the Beneficiaries who have exercised such right to purchase the Offered Beneficiary
Rights shall be entitled and obligated to purchase the entirety of such Offered Beneficiary Rights in proportion to their holdings
of Beneficiary Rights derived from this Trust vis a vis the other Beneficiaries who have also exercised such right to purchase
the Offered Beneficiary Rights.

 

(iii)
Transfer and ROFR Deposit. The Notice of Exercise shall be accompanied by a non-reimbursable deposit of no less than twenty
percent (20%) of the Minimum Price set forth in the Notice of Offer (the “ROFR Deposit”).

 

(iv)
The Transfer of the Offered Beneficiary Rights shall be made in favor of the non-transferring Beneficiary who delivered a Notice
of Exercise, on the same basis set forth in the Notice of Offer, within sixty (60) calendar days after the receipt of the Notice
of Exercise. The remaining portion of the Minimum Price must be paid by the non-transferring Beneficiary in immediately available
funds at closing of the Transfer.

 

(v)
If upon delivery of the Notice of Exercise the ROFR Deposit is not made, the Notice of Exercise shall be considered as not delivered
and the transferring Beneficiary shall have the right to Transfer the Offered Beneficiary Rights to the Third Party Purchaser
under the same material terms, including price, outlined to the non-transferring Beneficiary in the Notice of Offer. Notwithstanding
the foregoing, the transferring Beneficiary has the right to impose a penalty, in the amount of the respective ROFR Deposit, on
the non-transferring Beneficiary if the non-transferring Beneficiary made the ROFR Deposit but later fail(s) to consummate the
purchase of the Offered Beneficiary Rights pursuant to the terms of this Agreement for reasons attributed to the non-transferring
Beneficiary. In this event, the non-transferring Beneficiary shall forfeit the applicable ROFR Deposit.

 

    	 22

    	 	 	 

    

 

For
purposes of the Transfer of Beneficiary Rights between Beneficiaries, the only required representations and warranties shall be
those related to ownership of the Beneficiary Rights and nonexistence of liens and encumbrances thereupon.

 

(vi)
Termination of ROFR Exercise Period. If upon termination of the ROFR Exercise Period, a non-transferring Beneficiary: (i)
fails to timely deliver a Notice of Exercise regarding all of the Offered Beneficiary Rights in accordance with Section 4.1(b),
or (ii) having delivered the Notice of Exercise, does not purchase the Offered Beneficiary Rights pursuant to the terms set forth
above, the transferring Beneficiary shall be entitled to enter into a stock purchase agreement (the “Third Party Sale
Agreement”) with the Third Party Purchaser pursuant to which the transferring Beneficiary agrees to sell the Offered
Beneficiary Rights to such Third Party Purchaser under the same terms as those described in the Notice of Offer.

 

The
closing of the Transfer of all of the Offered Beneficiary Rights under this Clause IV will occur no later than ninety (90)
calendar days after the day the non-transferring Beneficiary received the Notice of Offer. If the Transfer is not made within
said ninety (90) calendar day term, the Transfer process set forth herein must once again be initiated. In the event the Transfer
of the Offered Beneficiary Rights requires third party or Governmental Authority authorization, said ninety (90) calendar day
term shall be extended as required by said third party or Governmental Authority to accept or reject the sale.

 

(vii)
Adhesion. In the event the Third Party Purchaser acquires all the Offered Beneficiary Rights owned by a Beneficiary in
this Trust Agreement, in order for said Transfer to be effective, simultaneously to the date on which the Transfer shall become
effective, the Third Party Purchaser must agree in writing to be bound by the terms and conditions set forth in this Agreement
and the Shareholder’s Agreement, on the same terms, mutatis mutandis, as the transferring Beneficiary was bound thereunder.

 

Any
Transfer that occurs with respect to the Beneficiary Rights without compliance with the terms set forth in this Clause IV
shall be null and void, and shall not be effective against the Trust or the Trustee, and the Trustee shall not record such transfer
in its record of Beneficiary Rights. In such event, the Third Party Purchaser may not exercise any rights pertaining to the Offered
Beneficiary Rights.

 

    	 23

    	 	 	 

    

 

(viii)
Void Assignments. Beneficiaries agree that any Transfer of Beneficiary Rights executed, directly or indirectly, through
any means, including transfer of beneficiary rights, partnership interests or similar equities in other companies or rights regarding
such equities, shall be void, and shall not be effective against the Trust, the Trustee or the Beneficiaries, and such Transfer
shall not be enforceable unless such Transfer of Beneficiary Rights complies with the provisions set forth in this Clause IV.

 

CLAUSE
V: DISPOSAL OF THE TRUST PROPERTY

 

Clause
5.1 Disposal of the Vitel Shares. Subject to the provisions of this Agreement and the Shareholders’ Agreement, Beneficiary
B may give written instructions to the Trustee of the terms pursuant to which the latter may perform the Transfer of all, or part,
of the Vitel Shares (including but not limited to a Transfer in connection with the termination of the Shareholders’ Agreement
upon the consummation of a Liquidation Event – as such term is defined in the Shareholders’ Agreement). The foregoing,
notwithstanding that Beneficiary B may give written instructions to the Trustee, of the terms pursuant to which the latter may
grant a special power of attorney for acts of ownership, in favor of the attorney in fact appointed by Beneficiary B, to perform
the Transfer of all or part of the Vitel Shares that form part of the Trust Property.

 

Clause
5.2 Disposal of the OBM Shares. Subject to the provisions of this Agreement and of the Shareholders’ Agreement, Beneficiary
A may give written instructions to the Trustee of the terms pursuant to which the latter may perform the Transfer of all, or part,
of the OBM Shares (including but not limited to the termination of the Shareholders’ Agreement upon the consummation of
a Liquidation Event – as such term is defined in the Shareholders’ Agreement). The foregoing, notwithstanding that
Beneficiary A may give written instructions to the Trustee, of the terms pursuant to which the latter may grant a special power
of attorney for acts of ownership, in favor of the attorney in fact appointed by Beneficiary A, to perform the Transfer of all
or part of the OBM Shares that form part of the Trust Property.

 

CLAUSE
VI: TRUST ACCOUNTS; PERMITTED INVESTMENTS

 

Clause
6.1 Trust Accounts.

 

(a)
General. On the execution date of this Agreement, the Trustee shall open the Trust Accounts, and keep them during the term
of this Agreement. Beneficiary A and Beneficiary B, as applicable, may instruct the Trustee to open one or more bank accounts
denominated in Pesos or in Dollars, as applicable. The Trustee may keep the Trust Account at Banco Actinver, S.A., in any of the
companies belonging to Grupo Financiero Actinver, or in any other financial institutions approved by the Beneficiaries, as applicable.
The Trustee shall receive and maintain in the Trust Accounts the funds contributed by the Beneficiaries while such funds are used
in terms of the written instructions it receives from the Beneficiaries, or, as applicable, it shall invest them in Permitted
Investments. Likewise, the Trustee shall provide the Distributions to the Beneficiaries, as applicable, with liquid funds deposited
into the Trust Account pursuant to the provisions of Clause VII below.

 

    	 24

    	 	 	 

    

 

(b)
Vitel Accounts. Beneficiary B may instruct the Trustee to open the accounts required to receive the Vitel Distributions,
and any other amount that the Trustee shall receive in its capacity as Vitel shareholder. The funds kept in the Vitel Accounts
shall be exclusively owned by Beneficiary B, and the Trustee may only dispose of such amounts in terms of the written instructions
it receives from Beneficiary B.

 

(c)
OBM Accounts. Beneficiary A may instruct the Trustee to open the accounts required to receive the OBM Distributions, and
any other amount that the Trustee shall receive in its capacity as OBM shareholder. The funds kept in the OBM Accounts shall be
exclusively owned by Beneficiary A, and the Trustee may only dispose of such amounts in terms of the written instructions it receives
from Beneficiary A.

 

Clause
6.2 Permitted Investment.

 

(a)
Standing Instructions. The Trustee shall invest the amounts deposited into the Trust Accounts in instruments with maturities
that do not exceed the following Business Day, denominated in Pesos, issued or secured by the Mexican Federal Government, with
a “AAA” credit rating in the national scale, or its equivalent, given by at least two of the rating agencies authorized
by the National Banking and Securities Commission (Comisión Nacional Bancaria y de Valores) (a “Permitted
Investment”).

 

(d)
Interest Rates. If the Permitted Investments are invested with the same financial institution to which the Trustee belongs,
such Permitted Investments shall pay interest rates at a higher rate than such institution pays for transactions with the same
maturity and similar amounts on the dates on which the deposits are made.

 

(e)
Investment Policies and Guidelines. When making the Permitted Investments pursuant to this Clause, the Trustee shall abide
by the guidelines and policies traditionally abided for similar transactions.

 

(f)
Preventive Measures. Pursuant to Circular Letter 1/2005 issued by the Mexican Central Bank, the Trustee has clearly and
unequivocally explained to the parties to this Agreement the following preventive measures included in item 5.4 of Circular Letter
1/2005:

 

(i)
The Trustee may perform credit transactions with Banco Actinver, S.A., acting on its own, provide that these are transactions
that the LIC, or provisions resulting therefrom, allow it to perform, and preventive measures are established to prevent conflict
of interest.

 

(ii)
The Beneficiaries expressly approve that Permitted Investments with Banco Actinver, S.A., or with any other financial institution
approved and instructed by the Beneficiaries, as applicable, to be performed.

 

(iii)
The rights and obligations of Banco Actinver, S.A., acting as Trustee, and on its own, shall not be extinguished as a result of
a merger of assets and liabilities.

 

    	 25

    	 	 	 

    

 

CLAUSE
VII: DISTRIBUTIONS

 

Clause
7.1 Distributions. Provided there are funds in the Trust Account, as applicable, the Beneficiaries, as applicable, shall
instruct the Trustee to distribute these within the Business Day following receipt in the Trust Accounts:

 

(i)
First, to pay the Trustee its fees, and reimburse expenses pursuant to Clause 2.5(g) of this Agreement.

 

(ii)
Second, 100% (one hundred percent) of the remainder, to Beneficiary A, and Beneficiary B, as applicable.

 

CLAUSE
VIII: INFORMATION; ACCOUNT STATEMENTS

 

Clause
8.1 Access to Information.

 

(a)
Beneficiary A. The Trustee shall provide Beneficiary A, when the latter so requests it in writing, all documentation and
information associated with this Trust in its capacity as an OBM shareholder.

 

(b)
Beneficiary B. The Trustee shall provide Beneficiary B, when the latter so requests it in writing, all documentation and
information associated with this Trust in its capacity as a Vitel shareholder.

 

Clause
8.2 Trust Account Statements.

 

The
Trustee will have a record log of all the operations carried out and will keep record of it in accordance with the applicable
law. Additionally, within the first 15 (fifteen) business days of each month, the electronic statement of the Trustee will be
available in the website www.actinver.com, which has an official and tax validity and contains a report of the state that the
Trust Property, having the Beneficiaries the same number of days after the issuance of the electronic statement to provide any
comments to the Trustee. In case such reports are not objected to by any of the Beneficiaries within the period set forth herein,
they will be understood as approved by the Beneficiaries.

 

In
accordance with the latter, the Trustors and Beneficiaries will execute Exhibit “B” regarding the “Paperless
Program” by means of which they grant their consent to avoid receiving their printed account statements.

 

Clause
8.3 Trustee Accounts and Records.

 

The
Trustee shall keep all accounts and records required to adequately record all transactions performed by the Trustee pursuant to
the provisions of this Agreement. The Trustee shall allow (i) Beneficiary A to review the accounts and records in connection with
its capacity as a Vitel shareholder, and (ii) Beneficiary B to review the accounts and records in connection with its capacity
as an OBM shareholder; the foregoing, provided that such visits shall be performed during business hours, and upon prior written
notice to the Trustee at least 3 (three) Business Days in advance.

 

    	 26

    	 	 	 

    

 

CLAUSE
IX: DEFENSE OF THE TRUST PROPERTY

 

Clause
9.1 Defense of the Trust Property.

 

(a)
In the event that defense of the Trust Property against a third party is required, the Trustee shall grant powers of attorney
in favor of the Person(s), and under the terms provided by the Beneficiaries, as applicable, in writing; provided that the Trustee
assumes no liability in connection with the actions performed by any such attorneys-in-fact, which provision shall be included
in the powers of attorney granted by the Trustee; provided, additionally, that each and every one of the reasonable costs, fees,
and expenses incurred by such attorneys-in-fact in exercise of such powers of attorney, shall be paid, solely and exclusively,
by the Beneficiaries, as applicable, at the expense of the Trust Property, without the Trustee incurring any liability in connection
with the foregoing.

 

(b)
In the event that urgent action is required, and it is necessary to take measures to preserve, and maintain the Trust Property,
the Trustee shall give immediate notice of such situation to the Beneficiaries, as applicable, and the Trustee may take all immediate
measures required to preserve and maintain the Trust Property, and the Trustee shall not be liable in connection with such immediate
measures, provided it acts pursuant to Applicable Law. Each and every one of the reasonable expenses incurred by the Trustee pursuant
to such measures shall be covered, solely and exclusively, at the expense of the Trust Property, and in the event that the latter
is insufficient, the Beneficiaries, as applicable, agree to reimburse any amount that the Trustee disbursed.

 

CLAUSE
X: TAX CONSIDERATIONS

 

Clause
10.1 Tax Obligations.

 

The
Beneficiaries shall pay, as applicable, and without limitation, all taxes of any kind, contributions, and other tax liabilities
that may be payable, imposed, or assessed in connection with executing this Agreement, and the distributions received pursuant
hereto (jointly, “Taxes”), and the Trustee shall not be liable in connection with the foregoing. The Trustee
shall not be required to calculate, withhold, and pay any taxes, assessments, fees, or duties, except as required by Applicable
Law. If for any reason the Trustee receives notice from any tax authority regarding any interpretation that the activities that
are the subject matter of this Agreement are deemed taxable and thus, the Trustee were required to withhold and pay any Taxes
pursuant to this Agreement, or any action associated with it, and the Beneficiaries, as applicable, ignore the notice that the
Trustee shall make of such events, and fail to appoint their respective representatives to defend the Trust Property (as applicable
to each of the Beneficiaries), the liable party, pursuant to what has been agreed herein, agrees to indemnify, and assist and
provide the necessary funds, and hold the Trustee, its shareholders, directors, trust officers, attorneys-in-fact, representatives,
advisors, or employees harmless against any actions in connection with such withholdings and payments, and if it were fined, or
otherwise sanctioned, the liable party pursuant to what has been agreed herein, agrees to directly and immediately reimburse any
expense or disbursement that the Trustee makes on this regard. The Trustee shall at all times have the right to be represented,
at the expense of the Trust Property (as applicable to the liable Beneficiary), by its own attorneys, advisors, and tax specialists
in connection with any tax obligations charged to it. Pursuant to the foregoing, the Beneficiary that is liable for the failure
to pay taxes agrees to indemnify, defend, and hold the Trustee, its shareholders, directors, trust officers, attorneys-in-fact,
representatives, advisors, or employees harmless from any liability and damages associated with payment of Taxes (including the
reasonable, and arm’s length fees and expenses of tax advisors and attorneys) resulting from entering into or performing
under this Agreement.

 

    	 27

    	 	 	 

    

 

If
applicable, the obligations resulting from the Foreign Account Tax Compliance Act (hereinafter “FATCA”) in connection
with the OBM Shares under this Agreement, shall be at the expense of the Beneficiaries jointly and in equal portions (50% Beneficiary
A and 50% Beneficiary B), for which, for the purpose of complying with such obligations, the parties agree that the Trustee, as
applicable, may grant a power of attorney with the required authorities to the person(s) that are designated by the Beneficiaries,
as applicable, as external advisors. Pursuant to the foregoing, the parties set forth that the Trustee shall not be liable for
the actions of the designated external advisors, with its obligation ceasing when the aforementioned power of attorney is granted.
The Trustee and Beneficiaries, as applicable, shall provide all documentation and information that they have, which is reasonably
requested by the external advisors designated to comply with the FATCA obligations. The parties agree that all expenses, duties,
taxes, commissions, fees, and other disbursements that, as applicable, are generated in connection with this Clause, shall be
paid at the expense of the Trust Property (as applicable to the liable Beneficiary) and, if there are no funds, or these are insufficient,
they shall be settled directly by the Beneficiaries, as applicable.

 

Clause
10.2 Reversion Right.

 

For
the tax purposes set forth in article 14 (fourteen) of the Federal Tax Code (Código Fiscal de la Federación)
in force, or any other that replaces it, the Beneficiaries reserve the right to reacquire, in whole or in part, the property and
rights that each of them contributed to the Trust Property, pursuant to the provisions of Clause XII below.

 

CLAUSE
XI: INDEMNITY

 

Clause
11.1 Indemnity.

 

The
Beneficiaries, as applicable, shall indemnify, defend, and hold the Trustee, and its officers, trust officers, executives, directors,
employees, and agents, harmless against any complaint, claim, fine, penalty, liability, settlement, damages, loss, cost, or expense
of any other kind (including, but not limited to, reasonable attorney fees and expenses) resulting from or incurred in connection
with this Agreement, or any other action, or failure to act, in connection herewith, except for those attributable to negligence,
willful misconduct, or bad faith of the Trustee, as determined by a court with jurisdiction.

 

    	 28

    	 	 	 

    

 

CLAUSE
XII: TERMINATION

 

Clause
12.1 Termination.

 

This
Trust Agreement shall remain in full force and effect until the terms and conditions applicable to the Trust Property have been
complied and performed in their entirety, and until this has been confirmed in writing, jointly by the Beneficiaries, except that
this Trust may be terminated when: (a) ownership of and title over the Trust Property are transferred pursuant to the Trust Purposes;
or (b) any of the circumstances set forth in article 392 (three hundred ninety-two) of the LGTOC (except for the provisions of
section VI (six) of such article 392 (three hundred ninety-two)) occurs.

 

In
the event that the Beneficiaries jointly instruct it in writing and it is permitted by the Shareholders Agreement, the Trustee
shall return ownership of and title over the Trust Property to the respective Beneficiaries, and these shall be required to receive
it. The parties agree to execute any documents required to comply with the terms of this Clause, including those that the Trustee
requires.

 

Clause
12.2 Maximum Term.

 

The
initial term of this Agreement will be 5 (five) years counted from its execution, and upon its expiration such term will subsequently
be automatically extended for 1 (one) additional 2 (two) year term, unless the Beneficiaries jointly give notice in writing to
the Trustee of their desire to terminate the present Agreement within 90 (ninety) calendar days in advance of the corresponding
expiration date, in the understanding that this Agreement may not exceed in any event the term set forth in subsection
III of article 394 of the LGTOC.

 

CLAUSE
XIII: MISCELLANEOUS

 

Clause
13.1 Legal Prohibitions.

 

Pursuant
to subsection (b) of section XIX of article 106 of the LIC, the Trustee represents that, through this Clause, it has clearly and
unequivocally explained to the parties to this Agreement the meaning and consequences of such article, which is herein transcribed
for the purposes that may apply:

 

“ARTICLE
106.- Credit institutions may not:

 

...

 

XIX.
When performing the transactions referenced in section XV, article 46 of this Law:

 

    	 29

    	 	 	 

    

 

A)
Repealed

 

B)
Be liable towards trustors, or principals, for breach by debtors, pursuant to loans granted, or by issuers, for securities acquired,
unless such breach is caused by them, pursuant to the provisions of the final part of article 391 of the General Law of Negotiable
Instruments and Credit Transactions, or guarantee returns for the funds whose investment is entrusted to them.

 

If
upon termination of the trust, mandate, or agency relationship created for the purpose of granting loans, these were not settled
by the debtors, the institution shall transfer them to the trustor or beneficiary, as applicable, or to the principal, abstaining
from paying its balance. 

 

In
trust, mandate, or agency agreements the above paragraphs shall be included in an evident way and a representation of the trustee
representing that it unequivocally provided such information to the persons which entrusted assets to such institution shall be
included.

 

C)
Act as trustees, or agents in trusts, mandate or agency agreements, respectively, through which funds from the public are obtained,
directly or indirectly, through any action that causes direct or contingent liabilities, except regarding trusts created by the
Federal Government, through the Ministry of Finance and Public Credit (Secretaría de Hacienda y Crédito Público)
and trusts through which securities are registered in the National Securities Registry (Registro Nacional de Valores), pursuant
to the provisions of the Securities Market Law (Ley del Mercado de Valores);

 

D)
Perform under the trust, mandate or agency agreements referenced in the second paragraph of article 88 of the Investment Companies
Law (Ley de Sociedades de Inversión); 

 

E)
Act in trust, mandate, or agency agreements through which restrictions or prohibitions contained in financial laws are evaded;

 

F)
Use funds or securities of the trust, mandate or agency agreements intended for providing loans, in which the Trustee has discretionary
authorities, to grant these for performing transactions pursuant to which their trust officers; the members of the board of directors
or steering committee;, as applicable, both principal and alternate, whether acting in such capacity or not; the employees and
officers of the institution, the principal or alternate statutory auditors, whether acting in such capacity or not; the members
of the technical committee of the relevant trust; the ascendant or descendant first degree relatives or spouses of the aforementioned
persons, the companies in whose meetings such persons or the same institutions have a majority, in addition to the persons that
the Mexican Central Bank determines pursuant to general regulations, become or could become debtors

 

    	 30

    	 	 	 

    

 

G)
Manage rural properties, unless they have been entrusted with their management, to distribute the estate among the heirs, legatees,
associates or creditors, or to pay a debt obligation or to secure their performance with the value of the property itself or of
its returns, and without, in these events, such management exceeding the term of two years, except regarding trusts for production
or security trusts, and

 

H)
Enter into trusts that manage sums of money periodically contributed by integrated consumer groups through marketing systems,
for the purpose of acquiring certain goods or services of those set forth in the Federal Consumer Protection Law (Ley Federal
de Protección al Consumidor).

 

Any
agreement contravening the above provisions shall be null and void...”

 

Likewise,
pursuant to the provisions set forth in section 5.5 of Circular Letter 1/2005 (as amended), issued by the Mexican Central Bank,
of the Rules to which Credit Institutions; Brokerage Firms; Insurance Companies; Surety Bond Companies, Limited Purpose Financial
Companies and the Financiera Rural Shall be Subject in Trust Transactions, the relevant provisions of section 6 of such
Circular Letter 1/2005 are transcribed for all legal purposes that may apply:

 

“6.
PROHIBITIONS

 

“6.1
When forming Trusts, Trust Companies may not:

 

a)
Charge to the trust property, prices different from those agreed upon completing the transaction in question; 

 

b)
Guarantee returns or prices for the funds whose investment they are entrusted; and 

 

c)
Perform transactions under conditions and terms that contravene their internal policies and sound financial practices. 

 

6.2
Trust Companies may not enter into transactions with securities, negotiable instruments, or any other kind of financial instrument
that do not comply with the specifications agreed in the relevant Trust Agreement. 

 

6.3
Trust Companies may not carry out the types of Trust Agreements that they are not authorized to enter into pursuant to the laws
and provisions that govern them.

 

6.4
In no event may Trust Companies pay, at the expense of trust property, any penalty imposed on such Companies by any authority.

 

    	 31

    	 	 	 

    

 

6.5
In security Trusts, Surety Companies and Sofoles (Limited Purpose Financial Companies) may not receive property or rights that
have as their purpose to secure the debt obligations in question. 

 

6.6
Trust Companies shall observe the provisions of articles 106 section XIX of the Credit Institutions Law, 103 section IX of the
Securities Market Law, 62 section VI of the General Law of Mutual Insurance Institutions and Companies (Ley General de Instituciones
y Sociedades Mutualistas de Seguros), 60 section VI Bis of the Federal Surety Companies Law (Ley Federal de Instituciones de Fianzas)
and 16 of the Organizational Law of the Rural Financial Institutions (Ley Orgánica de la Financiera Rural) as the case
may be for each Company.”

 

Pursuant
to section 5.5 of such Circular Letter 1/2005, the Trustee has informed the parties that the Trustee shall be liable for any damages
caused by its breach of its obligations under this Agreement, only if a judicial authority with jurisdiction determines that such
breach was caused by the Trustee.

 

Clause
13.2 Amendments.

 

This
Agreement may only be amended through a written agreement executed by the Beneficiaries, and the Trustee.

 

Clause
13.3 Assignment.

 

The
Beneficiaries may assign or transfer, in whole or in part, their rights and obligations resulting from this Agreement, pursuant
to the provisions of Clause IV of this Agreement.

 

The
Trustee may not assign, or otherwise transfer its respective rights and obligations resulting from this Agreement, without prior
written consent from the Beneficiaries, except as provided in Clause 2.5(f) of this Agreement regarding the replacement
of the Trustee.

 

Clause
13.4 Confidentiality.

 

The
parties to this Agreement agree to maintain confidentiality, and to not disclose any information associated with this Trust; provided
that those bound by this Clause may disclose any kind of information that (i) has been made available to the general public, unless
it is a result of a breach of this Clause, (ii) is required to be included in any report, representation, or document that may
be filed before any Governmental Authority, (iii) may be required as a response to any notices or summons in connection with any
litigation, (iv) is required to comply with any Applicable Law, including the U.S. securities laws, (v) is provided to the employees,
suppliers, and professional advisors of those bound, provided such employees, suppliers, and advisors are warned of the confidentiality
obligations set forth herein, and (vi) may be required by any Governmental Authority.

 

    	 32

    	 	 	 

    

 

Clause
13.5 Notices.

 

All
notices, requirements, and requests associated with this Agreement may be made in writing. All notices shall be deemed duly given
if they are given: (a) in person, with return receipt; or (b) through a specialized courier service, with return receipt; or (c)
via facsimile, upon written confirmation of receipt thereof; or (d) by email, upon written confirmation of receipt thereof. All
notices shall be given to the following addresses, facsimile numbers, emails, and shall become effective once they are received,
or when receipt thereof is refused, as provided in the return receipt, or in the receipt of the specialized courier service:

 

To
Beneficiary A – Manuel Cosme Odabachian:

 

	Address:	Secretaria
    de Marina 700 Torre Bambu Depto 2301
	 	Lomas
    del Chamizal
	 	Del.
    Cuajimalpa
	 	CP.
    05120 Mexico

Attention:
Manuel Cosme Odabachian

Telephone:
+52 55 1327 9067

Facsimile:
+52 55 5202 5854

Email:
mcosme@vitelpharma.com

 

To
Beneficiary A – Carlos Alaman Volnie:

 

	Address:	Tabachines
    72
	 	Bosques
    de las Lomas
	 	Del.
    Cuajimalpa
	 	CP.
    05120 Mexico

Attention:
Carlos Alaman Volnie

Telephone:
+52 55 5257 0848

Facsimile:
+52 55 5202 5854

Email:
calaman@vitelpharma.com

 

To
Beneficiary B:

 

	Address:	Oncbiomune
    Pharmaceuticals, Inc. 
	 	11441
    Industriplex Blvd., Suite 190
	 	Baton
    Rouge, LA 70809

Attention:
Andrew Albert Kucharchuk

Telephone:
225-227-2384

Facsimile:
225 227-2957

Email:
akucha1.OBMP@gmail.com

 

With
a copy (which shall not constitute notice) to:

 

	Address:
    	Legal
    & Compliance, LLC
	 	330
    Clematis Street, Suite 217
	 	West
    Palm Beach, FL 33401

Attention:
Lazarus Rothstein, Esq.

Telephone:
561-433-6217

Facsimile:
561-514-0832

Email:
lrothstein@legalandcompiance.com

 

    	 33

    	 	 	 

    

 

To
the Trustee:

 

	Address:
    	Montes
    Urales 540, Piso 4 Col,
	 	Lomas
    de Chapultepec, Delg. Miguel Hidalgo,
	 	CP
    11000, Ciudad de México

Attention:
Oscar Mejía Reyes and/or Daniel Abel Juárez Vilchis

Telephone:
01 (55) 86365550

Email:
fiducario@actinver.com.mx

 

The
parties to this Agreement agree that each and every instruction that shall be given to the Trustee pursuant to this Agreement
shall be given via facsimile or in pdf or similar format, sent as an attachment via email, or through personal delivery of the
instruction letter, and the Trustee is hereby authorized to act pursuant to the instructions given to it by such means, and it
is hereby released from any liability that may result from the issuance of such instructions.

 

The
Trustee shall not be required to verify the authenticity of such instructions or communications, or to verify the identity of
the Person sending or confirming them. Notwithstanding the foregoing, the Trustee shall have discretionary authorities, if it
has reasonable suspicion or justification, to act, or refrain from acting, or request confirmation of any instruction received
pursuant to this Agreement; provided that the Trustee shall give notice to the Beneficiaries, as applicable, as soon as possible,
in the event that the Trustee does not agree to act pursuant to such instructions until it receives confirmation thereof and will
act promptly after receiving such confirmation.

 

The
Trustee is hereby authorized to act pursuant to the instructions from the Beneficiaries, as applicable, in terms of the provisions
of this Agreement, given under the terms set forth in this Clause. In the event that any instruction is not signed pursuant to
the provisions of this Clause, or it may not be confirmed, the parties expressly instruct the Trustee not to act pursuant to such
instructions.

 

The
parties agree that the Trustee shall receive instructions from persons authorized to give them in terms of this Agreement, through
instruction letters, which shall be addressed to Banco Actinver, S.A., and shall be sent to the contractual address of the Trustee,
in a duly signed original, by the authorized person, via fax, or in the event it is expressly set forth in this Agreement, via
email. The parties expressly agree that the Trustee shall not be required to comply with any instruction that is sent via email,
or any other electronic or magnetic media different from a physical delivery, or via duly signed fax except as expressly provided
herein.

 

The
instruction letters described in the preceding paragraph to be followed by the Trustee shall include, at least, the following
requirements:

 

(i)
It shall be addressed to Banco Actinver, S.A.;

 

    	 34

    	 	 	 

    

 

(ii)
It shall make reference to the assigned trust number, and be grounded on the relevant clause of the Agreement;

 

(iii)
It shall contain the handwritten signature of whoever is/are authorized to give instructions in terms of this Trust Agreement,
who have been duly appointed and certified before the Trustee, sending to the latter, a copy of an official identification in
force containing their photograph and signature, and the signature shall coincide with that which is set in the relevant instruction.
If the Trustee already has such identification, it is not required to be attached; and

 

(iv)
It shall contain the express and clear instruction of what it wishes the Trustee to do, stating specific sums, amounts, or activities,
as applicable.

 

Failure
to comply with one or any of the aforementioned items shall release the Trustee from the obligation to comply with the instruction
contained in such letter, and it shall not be liable for the effects of its failure to act, until the errors of the aforementioned
instruction letter are cured.

 

Clause
13.6 Legal Fees. In the event that any Beneficiary obtains a ruling against the other Beneficiary pursuant to any breach
of this Agreement, the legal costs and expenses, including reasonable attorney fees, as determined by the court, shall be included
in such ruling.

 

Clause
13.7 Exhibits and Headings. All documents attached hereto, or that are referenced herein, are incorporated by reference,
and shall form an integral part of this Agreement. The titles and headings included in this Agreement are used solely for convenience
purposes, and shall not define, limit, or describe in any way the scope, or intent (or otherwise affect the construction) of any
provision of this Agreement.

 

Clause
13.8 Delivery of the Agreement. The delivery of the agreement is in compliance with the provisions set forth in section
5.1 (five point one) of Circular “1/2005” issued by Banxico, and the parties hereby receive an original copy of the
Trust Agreement, which they acknowledge for the corresponding legal effects.

 

Clause
13.9 Applicable Law and Jurisdiction. For all matters in connection with the interpretation and performance of this Agreement,
the parties hereby expressly and irrevocably submit to the applicable laws of Mexico City, and to the jurisdiction of the courts
with jurisdiction of Mexico City (formerly Federal District), therefore, they expressly and irrevocably waive any other jurisdiction
they may be entitled to pursuant to their current or future domiciles, or otherwise.

 

IN
WITNESS WHEREOF, the parties enter into and execute this Agreement through their respective duly authorized legal representatives,
on the date mentioned in the preamble.

 

[The
rest of the page is intentionally left blank. Signature pages follow.]

 

    	 35

    	 	 	 

    

 

Signature
page for the Irrevocable Management Trust Agreement Number F/2868 (two thousand eight hundred sixty eight) dated March 10, 2017,
entered into by and between Manuel Cosme Odabachian, Carlos Fernando Alaman Volnie and Oncbiomune Pharmaceuticals, Inc., in their
capacity as trustors and beneficiaries; and Banco Actinver, S.A., Institución de Banca Múltiple, Grupo Financiero
Actinver, in its capacity as trustee.

 

 

BANCO
ACTINVER, S.A., INSTITUCIÓN DE BANCA MÚLTIPLE,

GRUPO
FINANCIERO ACTINVER in its capacity as Trustee

 

By: /s/ Oscar Mejía Reyes  

Name:
 Oscar Mejía Reyes

 Its: Trust Officer 

 

By: /s/ Gabriela Alejandra Beltrán Espíndola

 Name:  Gabriela Alejandra Beltrán Espíndola 

Its:
Trust Officer

 

[The
rest of the page is intentionally left blank. Signature pages follow.]

 

    	 36

    	 	 	 

    

 

Signature
page for the Irrevocable Management Trust Agreement Number F/2868 (two thousand eight hundred sixty eight) dated March [*], 2017,
entered into by and between Manuel Cosme Odabachian, Carlos Fernando Alaman Volnie and Oncbiomune Pharmaceuticals, Inc., in their
capacity as trustors and beneficiaries; and Banco Actinver, S.A., Institución de Banca Múltiple, Grupo Financiero
Actinver, in its capacity as trustee.

 

The
TRUSTORS AND BENEFICIARIES A

 

By: /s/ Manuel Cosme Odabachian 

Name:
Manuel Cosme Odabachian 

On
his own behalf

 

By:
/s/ Carlos Fernando Alaman Volnie 

Name:
 Carlos Fernando Alaman Volnie 

On
his own behalf

 

[The
rest of the page is intentionally left blank. Signature pages follow.]

 

    	 37

    	 	 	 

    

 

Signature
page for the Irrevocable Management Trust Agreement Number F/2868 (two thousand eight hundred sixty eight) dated March 10, 2017,
entered into by and between Manuel Cosme Odabachian, Carlos Fernando Alaman Volnie and Oncbiomune Pharmaceuticals, Inc., in their
capacity as trustors and beneficiaries; and Banco Actinver, S.A., Institución de Banca Múltiple, Grupo Financiero
Actinver, in its capacity as trustee.

 

ONCBIOMUNE
PHARMACEUTICALS, INC.

in
its capacity as Trustor and Beneficiary B

 

By:
/s/ Andrew Albert Kucharchuk

Name:
Andrew Albert Kucharchuk

Its:
Attorney-in-fact

 

[The
rest of the page is intentionally left blank.]

 

    	 38

    	 	 	 

    

 

Exhibit
“A”

 

Copy
of Shareholders’ Agreement

 

    	 39

    	 	 	 

    

 

Exhibit
“B”

“Paperless
Program”

Trust
No. F/2868

 

The
“PAPERLESS” Program of Grupo Financiero Actinver allows you to check your monthly statement through our website without
sending it by mail to your domicile.

 

The
advantages of the Program are the following:

 

	 	●	Confidentiality
	 	●	Safety
	 	●	Easy
    Access

 

CONSENT

 

By
accepting the modality contained herein, you agree to not receive the printed statements corresponding to your account opened
pursuant to the Securities Brokerage Agreement linked to your Trust Agreement. In light of the foregoing, you will have access
to the information in respect of your statements through electronic means, in particular through the following website: www.actinver.com
(the “Website”) as long as the present consent has not been expressly revoked in writing to Grupo Financiero Actinver.

 

Therefore,
if you wish to receive your printed statements by mail please expressly and reliably give notice to Actinver by sending your instruction
to the address located at the bottom of this document, so that the new order is applied to the month immediately following the
date on which the corresponding notice is recorded.

 

We
inform you that the statements printed through the Actinver website are valid as tax proof in terms of the applicable laws, however,
you may request a printed copy of any statement that you have consulted to the address located at the bottom of this document.

 

Actinver
will not be liable in the event that the information regarding its statements is not received by you due to unforeseeable circumstances,
force majeure, system failures, interruptions in online communication systems, or any other cause outside the control of Grupo
Actinver. In any of the above situations, you must contact the Trustee Department in order to obtain the required attention, as
any disagreement regarding the movements that have been reflected on that statement must be filed within a period of no more than
sixty calendar days after the cut-off date of the same statement, since otherwise they will be understood as approved by you.

 

The
present document is issued in strict compliance with clause sixty six of the Stock Brokerage Agreement without prejudice to the
applicable legal and/or regulatory provisions.

 

[X]
I accept the terms and conditions.

 

[  ]
I do not accept the terms and conditions.

 

	Trustors
                                         and Beneficiaries “A”

                                                                                          

        Manuel
        Cosme Odabachian

         

        mcosme@vitelpharma.com

         

        Carlos
        Fernando Alaman Volnie

         

        calaman@vitelpharma.com
	 	Trustor
                                         and Beneficiary “B”

                                                                                          

        ONCBIOMUNE
        PHARMACEUTICALS, INC.

         

        Andrew
        Albert Kucharchuk

         

        akucha1.obmp@gmail.com

         

 

    	 40Execution
Version

 

STOCKHOLDERS’
AGREEMENT

 

dated
as of

 

March
10, 2017

 

among

 

ONCBIOMUNE
PHARMACEUTICALS, INC.

 

and

 

THE
STOCKHOLDERS PARTY HERETO

 

    	 	 	 

    	 		 

    

 

STOCKHOLDERS’
AGREEMENT (this “Agreement”), dated as of March 10, 2017, among:

 

(i)
OncBioMune Pharmaceuticals, Inc., a Nevada corporation (the “Company”);

 

(ii)
the individuals named as Management Stockholders on the signature pages hereto, and the individuals who are members of management
and become a party to this Agreement after the date hereof pursuant to the terms hereof (collectively, as listed on Schedule
A hereto, which may be amended by the Company to reflect changes in the Management Stockholders from time to time, each a
“Management Stockholder” and collectively, the “Management Stockholders”);

 

(iii)
Manuel Cosme Odabachian (“MCO”) and Carlos Fernando Alaman Volnie (“CAV”),
each a resident of Mexico (each a “Vitel Stockholder” and collectively, the “Vitel Stockholders”);
and

 

(iv)
the individuals (if any) who become a party to this Agreement as Additional Stockholders after the date hereof pursuant to the
terms hereof (collectively, as listed on Schedule A hereto, which may be amended by the Company to reflect changes in the
Additional Stockholders from time to time, each an “Additional Stockholder” and collectively, the “Additional
Stockholders”).

 

If
any Management Stockholder shall hereafter Transfer any of his or her Company Securities to any of his or her Permitted Transferees,
the term “Management Stockholder” as applied to such Management Stockholder shall mean such Management
Stockholder and his or her Permitted Transferees, taken individually and together, and any right, obligation or other action that
may be exercised or taken at the election of such Management Stockholder may be exercised or taken at the election of such Management
Stockholder and his or her Permitted Transferees.

 

If
any Vitel Stockholder shall hereafter Transfer any of his Company Securities to any of his respective Permitted Transferees (as
such terms are defined below), the term “Vitel Stockholder” shall mean such Vitel Stockholder and such
Permitted Transferees, taken individually and together, and any right, obligation or action that may be exercised or taken at
the election of such Vitel Stockholder may be exercised or taken at the election of such Vitel Stockholder and his Permitted Transferees.

 

If
any Additional Stockholder shall hereafter Transfer any of his or her Company Securities to any of his or her Permitted Transferees,
the term “Additional Stockholder” as applied to such Additional Stockholder shall mean such Additional
Stockholder and his or her Permitted Transferees, taken individually and together, and any right, obligation or other action that
may be exercised or taken at the election of such Additional Stockholder may be exercised or taken at the election of such Additional
Stockholder and his or her Permitted Transferees.

 

W
I T N E S S E T H :

 

WHEREAS,
the Company’s authorized capital stock consists of (i) 500,000,000 shares of common stock, par value $0.0001 per share,
and (ii) 20,000,000 shares of preferred stock, par value $0.0001 per share, and the Company currently had 61,158,013 shares of
common stock, and 1,000,000 shares of Series A preferred stock, issued and outstanding as of February 20, 2017;

 

    	 	 	 

    	 		 

    

 

WHEREAS,
the Company’s common stock is quoted on the OTCQB, operated by the OTC Markets Group;

 

WHEREAS,
MCO and CAV are the sole and exclusive owners of 98 shares (the “Vitel Shares”), together representing
98% of the capital fixed capital stock of Vitel Laboratorios, S.A. de C.V., a Mexican variable stock corporation (“Vitel”);

 

WHEREAS,
the Company, the Vitel Stockholders and Banco Actinver, S.A., Institución de Banca Múltiple, Grupo Financiero Actinver,
as Trustee (the “Trustee”), are contemporaneously herewith entering into (1) an Irrevocable Management
Trust Agreement Number F/2868, dated March 10, 2017, in the form attached hereto as Exhibit A (the “Trust
Agreement”), and (2) a Contribution Agreement to the Property of Trust F/2868, dated March 10, 2017, in the form
attached hereto as Exhibit B (the “Contribution Agreement” and together with the Trust
Agreement, the “Related Agreements”), for the purpose of establishing a vehicle for a business venture
between MCO and CAV and OBMP; and

 

WHEREAS,
it is the intention of the parties hereto to enter into this Agreement to govern certain of their rights, duties and obligations
upon and after the consummation of the transactions contemplated by the Related Agreements;

 

NOW,
THEREFORE, for good and valuable consideration the sufficiency and adequacy of which is hereby acknowledged, the parties hereto
agree as follows:

 

Article
1

DEFINITIONS

 

SECTION
1.01. Definitions.

 

(a)
The following terms, as used herein, have the
following meanings:

 

“Affiliate”
means, with respect to any Person, any other Person directly or indirectly controlling, controlled by or under common control
with such Person; provided that no securityholder of the Company shall be deemed an Affiliate of any other securityholder solely
by reason of an investment in the Company. For the purpose of this definition, the term “control” (including, with
correlative meanings, the terms “controlling”, “controlled by” and “under common control with”),
as used with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction
of the management and policies of such Person, whether through the ownership of voting securities, by contract or otherwise.

 

“Aggregate
Ownership” means, with respect to any Stockholder or group of Stockholders, the total number of the relevant class
of Company Securities owned (without duplication) by such Stockholder or group of Stockholders as of the date of such calculation,
calculated on a Fully-Diluted basis.

 

“Board”
means the board of directors of the Company.

 

    	 	2	 

    	 		 

    

 

“Business
Day” means any day except a Saturday, Sunday or other day on which commercial banks in New York City are authorized
by law to close.

 

“Bylaws”
means the amended and restated bylaws of the Company, as the same may be amended from time to time.

 

“Charter”
means the Amended and Restated Articles of Incorporation of the Company, as the same may be amended from time to time.

 

“Closing”
means the execution of this Agreement by the parties hereto, on the date hereof.

 

“Common
Shares” means shares of Common Stock.

 

“Common
Stock” means the Company’s common stock, par value $0.0001 per share, and any stock into which such Common
Stock may thereafter be converted, changed, reclassified or exchanged.

 

“Company
Securities” means (i) the Common Stock, (ii) any preferred stock, (iii) any other common stock issued by the Company
and (iv) any securities convertible into or exchangeable for, or options, warrants or other rights to acquire, Common Stock or
any other common stock issued by the Company.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

“Fair
Market Value” with respect to the Company Securities as of any date of determination, means:

 

(i)
the average of the opening and closing price per share of Common Stock, as of the date prior to the date hereof;

 

(ii)
if the Company Securities are listed or admitted to trading on a national securities exchange in the United States or reported
through The Nasdaq Stock Market (“Nasdaq”) then the closing sale price on such exchange or Nasdaq on
such date or, if no trading occurred or quotations were available on such date, then the closest preceding date on which such
Company Securities were traded or quoted; or

 

(iii)
if not so listed or reported but a regular, active public market for the Company Securities exists (as determined in the sole
discretion of the Board, whose discretion shall be conclusive and binding), then the average of the closing bid and ask quotations
per Company Security in the over-the-counter market for such Company Securities in the United States on such date or, if no such
quotations are available on such date, then on the closest date preceding such date. For purposes of the foregoing, a market in
which trading is sporadic and the ask quotations generally exceed the bid quotations by more than fifteen percent (15%) shall
not be deemed to be a “regular, active public market.”

 

If
the Board determines that a regular, active public market does not exist for the Company Securities, the Board shall determine
the Fair Market Value of the Company Securities in its good faith judgment.

 

    	 	3	 

    	 		 

    

 

“Fully
Diluted” means, with respect to any class of Company Securities, all outstanding shares and all shares issuable
in respect of securities convertible into or exchangeable for such shares, all stock appreciation rights, options, warrants and
other rights to purchase or subscribe for such class of Company Securities or securities convertible into or exchangeable for
such class of Company Securities; provided that if any of the foregoing stock appreciation rights, options, warrants or other
rights to purchase or subscribe for such class of Company Securities are subject to vesting, the Company Securities subject to
vesting shall be included in the definition of “Fully-Diluted” only upon and to the extent of such vesting.

 

“Group
of Stockholders” means a “group” of Stockholders, as such term would be interpreted under Section 13(d)
of the Exchange Act.

 

“Indemnified
Person” means indistinctively a Company Indemnified Person or a Vitel Stockholder Indemnified Person, as applicable.

 

“Indemnifying
Party” means the person granting the indemnities referred to in Article 6 hereof, which shall be either the
Vitel Stockholders or the Company, as applicable.

 

“Initial
Ownership” means, with respect to any Stockholder or group of Stockholders, the Aggregate Ownership by such Stockholder
or group of Stockholders as of the date hereof (or, in the case of any Additional Stockholder who becomes a party to this Agreement
after the date hereof, as of the date of joinder to or entry of such Additional Stockholder into this Agreement), in each case
taking into account any stock split, stock dividend, reverse stock split or similar event.

 

“Liquidation
Event” means any of the following events:

 

(i)
The sale, lease, transfer, exclusive license
or other disposition, in a single transaction or series of related transactions, by the Company or any Subsidiary of the Company
of all or substantially all of the assets of the Company and its Subsidiaries taken as a whole, or the sale or disposition (whether
by merger or otherwise) of one or more Subsidiaries of the Company if substantially all of the assets of the Company and its Subsidiaries
taken as a whole are held by such Subsidiaries;

 

(ii)
A transaction or series of related transactions
in which any Person or a group of Persons (as defined in Rule 13d-5(b) of the Exchange Act) acquires from stockholders of the
Company beneficial ownership (as determined in accordance with Rule 13d-3 under the Exchange Act) of Company Securities representing
more than fifty percent (50%) of the outstanding voting power of the Company; or

 

(iii)
A merger, consolidation or reorganization of
the Company or a Subsidiary of the Company with or into any other corporation, other than (A) any such transaction following which
the Company’s stockholders immediately prior to such transaction own immediately following such transaction, solely in respect
of the Company Securities held by them prior to such transaction, directly or indirectly through a parent corporation, greater
than fifty percent (50%) of the voting power of the equity securities of the surviving corporation, including any consolidation
with a wholly-owned Subsidiary and (B) a merger effected solely for the purpose of changing the domicile of the Company.

 

    	 	4	 

    	 		 

    

 

“Permitted
Transfer” means a Transfer to a Permitted Transferee, pursuant to Article 4 of this Agreement.

 

“Person”
means an individual, corporation, limited liability company, partnership, association, trust or other entity or organization,
including a government or political subdivision or an agency or instrumentality thereof.

 

“Plan”
means the Company 2011 Stock Option Plan.

 

“Pro
Rata Share” means, for each Stockholder, the fraction that results from dividing (A) such Stockholder’s Aggregate
Ownership of Company Securities by (B) the total number of shares of Company Securities then outstanding and owned by all Stockholders
(immediately before giving effect to such issuance), calculated on a Fully-Diluted Basis.

 

“Rule
144” means Rule 144 (or any successor provisions) under the Securities Act.

 

“SEC”
means the Securities and Exchange Commission.

 

“Securities
Act” means the Securities Act of 1933, as amended.

 

“Series
B Preferred Stock” means the Company’s Series B Preferred Stock, par value $0.0001 per share, and any stock
in to which such Series B Preferred Stock may thereafter be converted, changed, reclassified or exchanged.

 

“Stockholder”
means each Person (other than the Company) who, at any relevant determination date, shall be a party to or bound by this Agreement
(as may be amended from time to time) so long as such Person shall “beneficially own” (as such term is defined in
Rule 13d-3 of the Exchange Act) any Company Securities.

 

“Subsidiary”
means, with respect to any Person, any entity of which securities or other ownership interests having ordinary voting power to
elect a majority of the board of directors or other persons performing similar functions are at the time directly or indirectly
owned by such Person.

 

“Third
Party” means a prospective purchaser of Company Securities in a bona fide arm’s-length transaction from a
Stockholder, other than a Permitted Transferee or other Affiliate of such Stockholder.

 

“Transactions”
means the obligations of the Company to consummate the transactions contemplated by the Related Agreements

 

“Transfer”
means, with respect to any Company Securities, (i) when used as a verb, to sell, assign, dispose of, exchange, pledge, encumber,
hypothecate or otherwise transfer such Company Securities or any participation or interest therein, whether directly or indirectly,
or agree or commit to do any of the foregoing and (ii) when used as a noun, a direct or indirect sale, assignment, disposition,
exchange, pledge, encumbrance, hypothecation, or other transfer of such Company Securities or any participation or interest therein
or any agreement or commitment to do any of the foregoing.

 

    	 	5	 

    	 		 

    

 

(b)
Each of the following terms is defined in the
Section set forth opposite such term:

 

	TERM	 	SECTION
	AAA	 	5.07
	Additional Stockholder(s)	 	Preamble (iv)
	Agreement	 	Preamble 
	CAV 	 	Preamble (iii)
	Company	 	Preamble (i)
	Contribution Agreement	 	4th Recital
	Independent Designees	 	3.01(a)
	Major Decision	 	3.04
	Management Designee	 	3.01(a)
	Management Stockholder(s)	 	Preamble (ii)
	MCO 	 	Preamble (iii)
	Minimum Price	 	4.01(c)(i)
	Notice of Exercise	 	4.01(c)(ii)
	Notice of Offer	 	4.01(c)(i)
	OBM Shares	 	2.01
	Offered Company Securities	 	4.01(c)(i)
	Permitted Transfer	 	4.01(b)(i)
	Permitted Transferees	 	4.01(b)(i)
	Related Agreements	 	4th Recital
	Replacement Nominee	 	3.03(a)
	Right of First Refusal	 	4.01(c)
	ROFR Deposit	 	4.01(c)(iii)
	ROFR Exercise Period	 	4.01(c)(ii)
	Third Party Purchaser	 	4.01(c)(i)
	Third Party Sale Agreement	 	4.01(c)(vi)
	Trust Agreement 	 	4th Recital
	Trustee	 	4th Recital
	Vitel	 	3rd Recital
	Vitel Designee	 	3.01(a)
	Vitel Shares	 	3rd Recital
	Vitel Stockholder(s)	 	Preamble

 

(c)
Other Definitional and Interpretive Matters.
Unless otherwise expressly provided, for purposes of this Agreement, the following rules of interpretation shall apply:

 

Calculation
of Time Period. When calculating the period of time before which, within which or following which any act is to be done or
step taken pursuant to this Agreement, the date that is the reference date in calculating such period shall be excluded. If the
last day of such period is a non-Business Day, the period in question shall end on the next succeeding Business Day.

 

    	 	6	 

    	 		 

    

 

Dollars.
Any reference in this Agreement to $ shall mean U.S. dollars.

 

Exhibits/Schedules.
The Exhibits and Schedules to this Agreement are hereby incorporated and made a part hereof and are an integral part of this Agreement.
All Exhibits, Annexes and Schedules annexed hereto or referred to herein are hereby incorporated in and made a part of this Agreement
as if set forth in full herein. Any capitalized terms used in any Schedule, Annex or Exhibit but not otherwise defined therein
shall be defined as set forth in this Agreement.

 

Gender
and Number. Any reference in this Agreement to gender shall include all genders, and words imparting the singular number only
shall include the plural and vice versa.

 

Headings.
The provision of a Table of Contents, the division of this Agreement into Articles, Sections and other subdivisions and the insertion
of headings are for convenience of reference only and shall not affect or be utilized in construing or interpreting this Agreement.
All references in this Agreement to any “Section” are to the corresponding Section of this Agreement unless otherwise
specified.

 

Herein.
The words such as “herein,” “hereinafter,” “hereof,”
and “hereunder” refer to this Agreement as a whole and not merely to a subdivision in which such words
appear unless the context otherwise requires.

 

Article
2

TERMS OF THE TRANSACTIONS

 

SECTION
2.01. Establishment of Trust; Trust Contribution.
MCO, CAV and the Company shall establish the Trust. MCO and CAV shall each contribute, assign and transfer to the Company ownership
of, and title over, one Vitel Share and MCO and CAV shall contribute, assign and transfer to the Trustee ownership of, and title
over, the remaining Vitel Shares for the benefit of the Company pursuant to the terms and conditions of the Related Agreements.
The Company shall contribute, assign and transfer to the Trustee ownership of, and title over, 61,258,013 newly-issued shares
of Common Stock and 2,107,681 newly-issued shares of Series B Preferred Stock with 100 votes per share (collectively, the “OBM
Shares”), for the benefit of MCO and CAV pursuant to the terms and conditions of the Related Agreements. Each of
MCO and CAV understands and agrees that the OBM Shares held by the Trust have not been and will not be registered under the Securities
Act and are restricted securities under the Securities Act and the rules and regulations promulgated thereunder and are subject
to the restrictions on transfer contained in Article 4 of this Agreement.

 

SECTION
2.02. Property Rights. The property rights
resulting from the Vitel Shares contributed to the Trust will be exercised by the Trustee exclusively for the benefit, and in
terms of the written instructions it receives from, the Company as described in Clause 3.1(a) of the Trust Agreement while the
property rights resulting from the OBM Shares contributed to the Trust will be exercised by the Trustee exclusively for the benefit,
and in terms of the written instructions it receives from, MCO and CAV as described in Clause 3.1(b) of the Trust Agreement.

 

    	 	7	 

    	 		 

    

 

SECTION
2.03. Corporate Rights. The corporate
rights resulting from the Vitel Shares contributed to the Trust will be exercised by the Trustee pursuant to the written instructions
it receives from the Company. For such purposes, and pursuant to the bylaws of Vitel, the Company shall have the authority to
instruct the Trustee regarding exercising any corporate rights it may be entitled to in its capacity as the majority Vitel shareholder,
including, but not limited to, calling shareholder meetings, voting the Vitel Shares pursuant to the instructions given by the
Company, executing unanimous written consents in lieu of a meeting, adopting resolutions agreeing to pay the Vitel Distributions
(as such term is defined in the Trust Agreement) and, in general, resolve any and all matters associated with Vitel, and exercising
any other right it may be entitled to in its capacity as the majority Vitel shareholder, pursuant to the provisions of the Trust
Agreement, the Vitel bylaws and applicable law. The corporate rights resulting from the OBM Shares contributed to the Trust will
be exercised by the Trustee pursuant to the written instructions it receives from MCO and CAV. For such purposes and pursuant
to the bylaws of the Company and this Agreement, MCO and CAV shall have the authority to instruct the Trustee regarding exercising
any corporate rights it may be entitled to in its capacity as a Vitel Stockholder, including, but not limited to, calling shareholder
meetings, voting the OBM Shares pursuant to the instructions given by MCO and CAV, executing unanimous written consents in lieu
of a meeting, adopting resolutions agreeing to pay the OBM Distributions (as such term is defined in the Trust Agreement) and,
in general, resolve any and all matters associated with OBM, and exercising any other right it may be entitled to in its capacity
as a Vitel Stockholder pursuant to the provisions of the Trust Agreement, this Agreement, the Bylaws and Nevada corporate law.

 

Article
3

CORPORATE GOVERNANCE

 

SECTION
3.01. Composition of the Board.

 

(a)
The Board of the Company currently consists of
five (5) directors. Following the Closing, the Stockholders shall take such actions as may be required so that the Board of the
Company shall consist of four (4) directors, including at least one (1) designated by the Vitel Stockholders, one (1) designated
by the Management Stockholders, and two (2) independent directors shall be designated jointly by the Management Stockholders and
the Vitel Stockholders, in the understanding that the Management Stockholders or the Management Designee and the Vitel
Stockholders or the Vitel Designee shall jointly appoint, as soon as practicable, an independent fifth member of the Board of
the Company. MCO shall be the initial designee of the Vitel Stockholders to the Board (the “Vitel Designee”),
Jonathan F. Head, Ph.D. shall be the initial designee of the Management Stockholders (the “Management Designee”),
and Charles L. Rice, Jr. and Daniel S. Hoverman shall be the initial independent designees jointly appointed by the Management
Stockholders and the Vitel Stockholders (hereinafter all Board members which are not the Vitel Designee or the Management Designee,
the “Independent Designees”).

 

(b)
Each Stockholder agrees that, if at any time
it is then entitled to vote for the election of directors to the Board, it shall vote all of its Company Securities that are entitled
to vote or execute proxies or written consents, as the case may be, and take all other necessary action (including causing the
Company to call a special meeting of Stockholders) in order to ensure that (1) the composition of the Board is as set forth in
this Section 3.01 and (2) the slate of directors proposed by the Board for election by the stockholders of the Company
is elected.

 

    	 	8	 

    	 		 

    

 

(c)
The Company agrees to cause each individual designated
pursuant to Section 3.01(a) or 3.03 to be nominated to serve as a director on the Board, and to take all other necessary
actions (including calling a special meeting of the Board and/or Stockholders) to ensure that the composition of the Board is
as set forth in this Section 3.01.

 

SECTION
3.02. Removal. Each Stockholder agrees
that, if at any time it is then entitled to vote for the removal of directors from the Board, it shall not vote any of its Company
Securities in favor of the removal of any director who shall have been designated by the Vitel Stockholders pursuant to Section
3.01, unless the Vitel Stockholders shall have consented to such removal in writing; provided that if the Vitel Stockholders
shall request in writing the removal of such director, such Stockholder shall vote all its Company Securities that are entitled
to vote in favor of such removal.

 

SECTION
3.03. Vacancies. If, as a result of death,
disability, retirement, resignation, removal or otherwise, there shall exist or occur any vacancy on the Board of any director
who shall have been designed by the Vitel Stockholders pursuant to Section 3.01:

 

(a)
The Vitel Stockholders may designate another
individual (the “Replacement Nominee”) to fill such vacancy and serve as a director on the Board; and

 

(b)
each Stockholder then entitled to vote for the
election of directors to the Board agrees that it shall vote all of its Company Securities that are entitled to vote or execute
proxies or written consents, as the case may be, in order to ensure that the Replacement Nominee be elected to the Board.

 

SECTION
3.04. Board Resolutions. The Board of
Directors shall adopt any and all resolutions with a vote from a majority of its members, provided that for any
of the matters included in Exhibit D hereto (each a “Major Decision”) either the Vitel
Designee or the Management Designee shall vote in favor of adopting the corresponding resolution. In the event of a deadlock amongst
the members of the board of directors of Vitel, the Board of Directors shall cast the deciding vote to resolve the deadlock amongst
the board members of Vitel with a vote from a majority of its members, subject to the provision set forth above in connection
with Major Decisions regarding Subsidiaries of the Company.

 

SECTION
3.05. Charter or Bylaw Provisions. Each
Stockholder agrees to vote all of its Company Securities that are entitled to vote or execute proxies or written consents, as
the case may be, and to take all other actions necessary, to ensure that the Company’s Charter and Bylaws (a) facilitate,
and do not at any time conflict with, any provision of this Agreement and (b) permit each Stockholder to receive the benefits
to which each such Stockholder is entitled under this Agreement. In addition, on the date hereof, Vitel Stockholders and Management
Stockholders shall sign, or direct the Trustee to sign, the written consents necessary to amend the Company’s Charter and
Bylaws, substantially in the form of the documents attached hereto as Exhibit E.

 

    	 	9	 

    	 		 

    

 

SECTION
3.06. Reimbursement of Expenses. Directors
will not be entitled to compensation for service on the Board but the Company will pay all reasonable out-of-pocket expenses incurred
by the members of the Board in connection with traveling to and from and attending meetings of the Board and while conducting
business at the request of the Company.

 

SECTION
3.07. Corporate Opportunities. The parties
also acknowledge that the Vitel Stockholders and their Affiliates have or may have interests in the same, related or competitive
business areas as those engaged in by the Company and its Subsidiaries. For the avoidance of doubt, the Vitel Stockholders and
their Affiliates shall be free to pursue only those opportunities permitted by Clause 5.2 of the Contribution Agreement without
offering those opportunities to the Company.

 

SECTION
3.08. Protective Covenants. At and after
such time that the Vitel Designee shall have been elected to the Board pursuant to Section 3.01, the Company shall not
(a) amend, alter or repeal any provision of the Charter or Bylaws of the Company relating to the Board as contemplated in this
Article 3, and (b) alter the size or composition of the Board other than in accordance with Sections 3.01 and 3.03
of this Agreement, without the prior written approval of the Vitel Designee (including any Replacement Nominees).

 

Article
4

RESTRICTIONS ON TRANSFER

 

SECTION
4.01. General Restrictions on Transfer.

 

(a)
Each Stockholder understands and agrees that
the Company Securities held by it on the date hereof have not been and will not be registered under the Securities Act and are
restricted securities under the Securities Act and the rules and regulations promulgated thereunder. Each Stockholder agrees that
it shall not Transfer any Company Securities (or solicit any offers in respect of any Transfer of any Company Securities), except
in compliance with the Securities Act, any other applicable securities or “blue sky” laws and any other restrictions
on Transfer contained in this Agreement and Clause IV of the Trust Agreement. Moreover, the restrictions on transfer included
in Sections 4.01(c), (d) and (e) hereof are subject to the Company deregistering all its Company Securities
with the Securities and Exchange Commission of the United States of America before such restrictions shall apply.

 

(b)
Permitted Transfers.

 

(i)
Notwithstanding anything to the contrary in this Agreement, the Stockholders that are a party hereto may at any time, without
being subject to Clause 4.01, Transfer their respective Company Securities (whether being held directly or indirectly through
the trustee of the Trust Agreement) (x) to any of their Affiliates, their spouse, children, grandchildren, parents, sisters, brothers,
nieces, nephews or any other relative within the second degree of kindred or a trust or other entity under a Stockholder’s
control (the “Permitted Transferees”), or (y) with the prior consent of the other Stockholders which are also
a party hereto, or (z) as otherwise permitted under this Agreement (each, a “Permitted Transfer”), in the understanding
that (1) each Management Stockholder will be considered a Permitted Transferee with respect to each other and each Vitel Stockholder
will be considered a Permitted Transferee with respect to each other, (2) transfers by the Stockholders that are a party hereto
resulting from their death shall be considered a Permitted Transfer, and (3) any Stockholder that is a party hereto may act individually
in regards to this Clause.

 

    	 	10	 

    	 		 

    

 

(ii)
If a Permitted Transferee ceases to be an Affiliate of the Stockholder that is a party hereto who Transferred Company Securities
to such Permitted Transferee, such Transfer shall be null and void pursuant to Section 4.01(d) hereof. The agreement or other
instrument pursuant to which a party hereto carries out a Permitted Transfer must specifically contain a provision expressly contemplating
the reversion of Company Securities or unwinding of the Permitted Transfer should the transferee cease to be a Permitted Transferee
at any time after the corresponding Transfer. If according to the applicable law such reversion is not permitted or the transferor
does not accept such reversion, then the non-transferring parties hereto shall be entitled to, provided that the transferor is
bound to take any action that may be required from its part: (x) acquire directly or through an Affiliate, the totality of the
Company Securities of the Permitted Transferee that ceased to be an Affiliate, (y) to instruct the Company to carry out a capital
reduction in order to redeem the Company Securities of the Permitted Transferee that ceased to be an Affiliate, and to cause the
corresponding Affiliate to approve and participate in such reduction, or (z) a combination of the rights set forth in (x) and
(y) of this subsection (ii). In the event that more than one non-transferring party hereto exercises its right to acquire the
Company Securities of the Permitted Transferee that ceased to be an Affiliate, the parties hereto who have exercised such right
to purchase the Company Securities of the Permitted Transferee that ceased to be an Affiliate shall be entitled and obligated
to purchase the entirety of such Company Securities in proportion to their holdings of Company Securities vis a vis the
other parties hereto who have also exercised such right to purchase such Company Securities. The agreement or other instrument
pursuant to which a party hereto carries out a Permitted Transfer must specifically contain a provision expressly granting such
rights to the non-transferring parties hereto.

 

(iii)
Each transferring Stockholder that is a party hereto shall previously notify in writing the non-transferring Stockholders that
are also a party hereto of any Permitted Transfer.

 

(iv)
Notwithstanding anything to the contrary in this clause, Vitel Stockholders may only carry out Permitted Transfers after 3 (three)
years from the execution of this Agreement and any Permitted Transfer by Vitel Stockholders shall be made only to Mexican Affiliates.

 

(v)
Any attempted Transfer in violation of the terms of this Section shall be null and void.

 

(c)
Right of First Refusal. Subject to the
provisions in this Article 4 (particularly the last sentence of Section 4.01(a)), in the event a Stockholder that is a party hereto
wishes to Transfer its Company Securities (other than a transfer which is part of an acquisition or strategic transaction approved
by the directors of OBM as a Major Decision), the other non-transferring Stockholders that are also a party hereto shall have
the irrevocable right of first refusal (“Right of First Refusal”), pursuant to the following terms and conditions:

 

    	 	11	 

    	 		 

    

 

(i)
Notice of Offer. In the event a Stockholder
that is a party hereto, directly or indirectly, at any time, wishes or has the intention to Transfer any of its Company Securities
to a third party other than an Affiliate (and other than a transfer which is part of an acquisition or strategic transaction approved
by the directors of OBM as a Major Decision), such transferor must deliver written notice of such intention to the other Stockholders
that are a party hereto, with a copy to the Company (the “Notice of Offer”), indicating (1) the amount of Company
Securities owned by the transferor that are subject to such Transfer (the “Offered Company Securities”), (2)
the purchase price (the “Minimum Price”) for such Offered Company Securities, (3) all other material terms
and conditions of the proposed Transfer, including payment terms and the identity of the potential third party purchaser (the
“Third Party Purchaser”) with sufficient detail and (4) the terms and conditions contained in the Notice of
Offer shall be maintained for a transfer to any other Stockholder that is also a party hereto, in the event of a Notice of Exercise
(as described below).

 

(ii)
ROFR Exercise Period. The non-transferring
Stockholder, within thirty (30) calendar days after the receipt of the Notice of Offer (the “ROFR Exercise Period”),
may choose to either (i) purchase the Offered Company Securities, or (ii) not respond to the Notice of Offer. In the event a non-transferring
Stockholder wishes to purchase the Offered Company Securities, it must exercise its Right of First Refusal by written notice (“Notice
of Exercise”) given to the transferring Stockholder of its intent to purchase all, and not less than all, of the Offered
Company Securities on the terms contained in the Notice of Offer, at the proposed Minimum Price. In the event that more than one
Stockholder exercises its right to acquire the Offered Company Securities, the Stockholders who have exercised such right to purchase
the Offered Company Securities shall be entitled and obligated to purchase the entirety of such Offered Company Securities in
proportion to their holdings of Company Securities vis a vis the other Stockholder who may have also exercised such right
to purchase the Offered Company Securities.

 

(iii)
Transfer and ROFR Deposit. The Notice
of Exercise shall be accompanied by a non-reimbursable deposit of no less than twenty percent (20%) of the Minimum Price set forth
in the Notice of Offer (the “ROFR Deposit”).

 

(iv)
The Transfer of the Offered Company Securities
shall be made in favor of the non-transferring Stockholder(s) who delivered a Notice of Exercise, on the same basis set forth
in the Notice of Offer, within sixty (60) calendar days after the receipt of the Notice of Exercise. The remaining portion of
the Minimum Price must be paid by the non-transferring Stockholder(s) in immediately available funds at closing of the Transfer.

 

(v)
If upon delivery of the Notice of Exercise the
ROFR Deposit is not made, the Notice of Exercise shall be considered as not delivered and the transferring Stockholder shall have
the right to Transfer the Offered Company Securities to the Third Party Purchaser under the same material terms, including price,
outlined to the non-transferring Stockholders in the Notice of Offer. Notwithstanding the foregoing, the transferring Stockholder
has the right to impose a penalty, in the amount of the respective ROFR Deposit, on the non-transferring Stockholder(s) if the
non-transferring Stockholder(s) made the ROFR Deposit but later fail(s) to consummate the purchase of the Offered Company Securities
pursuant to the terms of this Agreement for reasons attributed to the non-transferring Stockholder(s). In this event, the non-transferring
Stockholder(s) shall forfeit the applicable ROFR Deposit.

 

    	 	12	 

    	 		 

    

 

For
purposes of the Transfer of Company Securities between Stockholders pursuant to the terms hereof, the only required representations
and warranties shall be those related to ownership of the Company Securities and nonexistence of liens and encumbrances thereupon.

 

(vi)
Termination of ROFR Exercise Period. If
upon termination of the ROFR Exercise Period, a non-transferring Stockholder(s): (i) fail(s) to timely deliver a Notice of Exercise
regarding all of the Offered Company Securities in accordance with Section 4.01(c)(ii), or (ii) having delivered the Notice of
Exercise, does not purchase the Offered Company Securities pursuant to the terms set forth above, the transferring Stockholder
shall be entitled to enter into a stock purchase agreement (the “Third Party Sale Agreement”) with the Third
Party Purchaser pursuant to which the transferring Stockholder agrees to sell the Offered Company Securities to such Third Party
Purchaser under the same terms as those described in the Notice of Offer.

 

The
closing of the Transfer of all of the Offered Company Securities under this Article IV will occur no later than ninety
(90) calendar days after the day the non-transferring Stockholder received the Notice of Offer. If the Transfer is not made within
said ninety (90) calendar day term, the Transfer process set forth herein must once again be initiated. In the event the Transfer
of the Offered Company Securities requires any additional third party or governmental authority authorization, said ninety (90)
calendar day term shall be extended as required by said third party or governmental authority to accept or reject the sale.

 

(vii)
Adhesion. In the event the Third Party
Purchaser acquires all the Offered Company Securities owned by a Stockholder, in order for said Transfer to be effective, simultaneously
to the date on which the Transfer shall become effective, the Third Party Purchaser (a) shall have agreed in writing to be bound
by the terms of this Agreement by executing a joinder agreement in the form of Exhibit C attached hereto; and (b)
the Transfer shall be in compliance with the Securities Act, any other applicable securities or “blue sky” laws and
any other restrictions on Transfer contained in this Agreement. Third Party Purchaser shall also provide the Company any such
other information reasonably requested by the Company to ensure compliance with the terms of this Agreement and the Company shall
be entitled to condition any such Transfer on receipt of an opinion of counsel reasonably acceptable to the Company that such
Transfer is exempt from the registration requirements of the Securities Act.

 

    	 	13	 

    	 		 

    

 

(vi)
Any attempted Transfer in violation of the terms of this Agreement shall be null and void.

 

(d)
Right of Co-Sale (Tag Along). Subject
to the provisions of the last sentence of Section 4.01(a), in the event that any Stockholder or group of Stockholders intend to
accept an offer (either solicited or unsolicited) from any third party to acquire or otherwise Transfer Company Securities, representing
at least 20% (twenty per cent) of the outstanding Company Securities, on a Fully Diluted basis, the selling Stockholder shall
give an offer notice in writing to the Stockholders of the Company, with a copy to the Company, containing the terms and conditions
of such offer received from the interested third party. Each Stockholder shall have the right to participate in such offer by
selling the pro rata proportion of its Company Securities pursuant to such offer to acquire or otherwise Transfer Company Securities.

 

(e)
Drag Along. In the event a Stockholder
or group of Stockholders representing at least 32% (thirty two per cent) of the outstanding Company Securities, on a Fully Diluted
basis, intends to accept an offer from any third party to acquire or otherwise Transfer Company Securities, representing at least
50% (fifty per cent) of the outstanding Company Securities, on a Fully Diluted basis, and the transaction is approved by the Company’s
board of directors as a Major Decision, then each Stockholder shall be obligated to sell its Company Securities pursuant to the
offer to purchase. In case the drag along provision included herein is enforced, all the Stockholders participating in such sale
shall receive the same terms and conditions of sale based on their respective holdings of Company Securities and shall otherwise
be treated equally based on such ownership interest.

 

(f)
Any attempt to Transfer any Company Securities
not in compliance with this Agreement shall be null and void, and the Company shall not, and shall cause any transfer agent not
to, give any effect in the Company’s stock records to such attempted Transfer.

 

SECTION
4.02. Legends.

 

(a)
In addition to any other legend that may be required,
each certificate for Company Securities issued to any Stockholder shall bear a legend in substantially the following form:

 

“THIS
SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY FOREIGN OR STATE SECURITIES LAWS AND MAY
NOT BE OFFERED OR SOLD EXCEPT IN COMPLIANCE THEREWITH. THIS SECURITY IS ALSO SUBJECT TO ADDITIONAL RESTRICTIONS ON TRANSFER AS
SET FORTH IN THE STOCKHOLDERS’ AGREEMENT DATED AS OF MARCH 10, 2017, COPIES OF WHICH MAY BE OBTAINED UPON REQUEST FROM ONCBIOMUNE
PHARMACEUTICALS, INC. OR ANY SUCCESSOR THERETO.”

 

(b)
If any Company Securities (i) are sold under
circumstances in which all of the applicable conditions of Rule 144 (or any similar provisions then in force) under the Securities
Act are met or (iii) are otherwise Transferred, the Company has delivered a new certificate or other evidence of ownership for
such Company Securities not bearing the legend required pursuant to this Agreement and such Company Securities may be resold without
subsequent registration under the Securities Act, the Company may request that the holder provide an opinion of legal counsel
reasonably acceptable to the Company stating that such Company Securities are freely transferable under the Securities Act, and
if it requests and receives such opinion, the Company shall issue to such holder a new certificate evidencing such Company Securities
without the first sentence of the legend required by Section 4.03(a) endorsed thereon. If any Company Securities cease
to be subject to any and all restrictions on Transfer and all other obligations set forth in this Agreement and Clause IV of the
Trust Agreement, the Company, upon the written request of the holder thereof, shall issue to such holder a new certificate evidencing
such Company Securities without the second sentence of the legend required by Section 4.03(a) endorsed thereon.

 

    	 	14	 

    	 		 

    

 

SECTION
4.03. Permitted Transferees. The provisions
of this Article 4 shall apply with respect to Permitted Transfers by any Stockholders that are a party hereto, provided
that (a) subject to the provisions of Section 5.04(c) hereof, any Permitted Transferee shall have agreed in writing to
be bound by the terms of this Agreement by executing a joinder agreement in the form of Exhibit C attached hereto;
and (b) the Transfer is in compliance with the Securities Act, any other applicable securities or “blue sky” laws
and any other restrictions on Transfer contained in this Agreement. Such Stockholder must give written prior notice to the Company
of any proposed Transfer to a Permitted Transferee, including the identity of such proposed Permitted Transferee and such other
information reasonably requested by the Company to ensure compliance with the terms of this Agreement and the Company shall be
entitled to condition any such Transfer on receipt of an opinion of counsel reasonably acceptable to the Company that such Transfer
is exempt from the registration requirements of the Securities Act.

 

SECTION
4.04. Restrictions on Transfers by Additional
Stockholders. The right of the Additional Stockholders to Transfer any of their Company Securities shall be limited solely
by applicable Federal and state securities laws.

 

SECTION
4.05. Liquidation Event. Upon the occurrence
of a Liquidation Event, the Vitel Stockholders shall give written instructions to the Trustee to perform the Transfer each such
Vitel Stockholder’s Pro Rata Share of the OBM Shares that form part of the Trust Property to be sold as part of the Liquidation
Event. The Vitel Stockholders shall be responsible for the tax consequences to each of them of their participation in any such
Liquidation Event.

 

Article
5

MISCELLANEOUS

 

SECTION
5.01. Conflicting Agreements. Each Stockholder
represents and agrees that it shall not (a) grant any proxy or enter into or agree to be bound by any voting trust or agreement
with respect to the Company Securities, except as expressly contemplated by this Agreement, (b) enter into any agreement or arrangement
of any kind with any Person with respect to its Company Securities inconsistent with the provisions of this Agreement or for the
purpose or with the effect of denying or reducing the rights of any other Stockholder under this Agreement, including agreements
or arrangements with respect to the Transfer or voting of its Company Securities or (c) act, for any reason, as a member of a
group or in concert with any other Person in connection with the Transfer or voting of its Company Securities in any manner that
is inconsistent with the provisions of this Agreement.

 

    	 	15	 

    	 		 

    

 

SECTION
5.02. Binding Effect; Assignability; Benefit.

 

(a)
This Agreement shall inure to the benefit of
and be binding upon the parties hereto and their respective heirs, successors, legal representatives and permitted assigns. Any
Stockholder that ceases to own beneficially any Company Securities shall cease to be bound by the terms hereof (other than this
Article 5).

 

(b)
Neither this Agreement nor any right, remedy,
obligation or liability arising hereunder or by reason hereof shall be assignable by any party hereto pursuant to any Transfer
of Company Securities or otherwise. Any Person acquiring Company Securities that is required or permitted by the terms of this
Agreement to become a party hereto shall (unless already bound hereby) execute and deliver to the Company an agreement to be bound
by this Agreement in the form of Exhibit C hereto and shall thenceforth be a “Stockholder”.

 

(c)
Nothing in this Agreement, expressed or implied,
is intended to confer on any Person other than the parties hereto, and their respective heirs, successors, legal representatives
and permitted assigns, any rights, remedies, obligations or liabilities under or by reason of this Agreement.

 

SECTION
5.03. Notices. All notices, requests and
other communications to any party shall be in writing and shall be delivered in person, mailed by certified or registered mail,
return receipt requested, or sent by email,

 

If
to the Company, to:

 

OncBioMune
Pharmaceuticals, Inc.

11441
Industriplex Blvd., Suite 190

Baton
Rouge, LA 70809

Attention:
Andrew Albert Kucharchuk

Email:
akucha1.OBMP@gmail.com

With
a copy (which shall not constitute notice) to:

 

Legal
& Compliance, LLC

330
Clematis Street, Suite 217

West
Palm Beach, FL 33401

Attention:
Lazarus Rothstein, Esq.

Email:
lrothstein@legalandcompiance.com

 

If
to the Vitel Stockholders:

 

Manuel
Cosme Odabachian

Secretaria
de Marina 700 Torre Bambu Depto 2301

Lomas
del Chamizal

De.
Cuajimalpa

CP.
05120 Mexico

Email:
mcosme@vitelpharma.com

 

    	 	16	 

    	 		 

    

 

Carlos
Fernando Alaman Volnie

Tabachines
72

Bosques
de Las Lomas

Del.
Cuajimalpa

CP.
05120 Mexico

Email:
calaman@vitelpharma.com

 

if
to any other Stockholder, to such Stockholder at the address listed on Schedule A hereto,

 

or,
in each case, at such other address or email as such party may hereafter specify for the purpose of notices hereunder by written
notice to the other parties hereto. All notices, requests and other communications shall be deemed received on the date of receipt
by the recipient thereof if received prior to 5:00 p.m. in the place of receipt and such day is a Business Day in the place of
receipt. Otherwise, any such notice, request or communication shall be deemed not to have been received until the next succeeding
Business Day in the place of receipt. Any notice, request or other written communication sent by email transmission shall be deemed
received upon confirmation of receipt by the receiving party.

 

Any
Person that hereafter becomes a Stockholder shall provide its address and email to the Company, which shall promptly provide such
information to each other Stockholder.

 

SECTION
5.04. Waiver; Amendment; Termination.

 

(a)
No provision of this Agreement may be waived
except by an instrument in writing executed by the party against whom the waiver is to be effective. No provision of this Agreement
may be amended or otherwise modified except by an instrument in writing executed by the Company and the Vitel Stockholders and
if any such amendment or modification will disproportionately and materially and adversely affect the other Stockholders differently
than the Vitel Stockholders, the other Stockholders holding at least 51% of the outstanding Common Shares held by the other Stockholders
at the time of such proposed amendment or modification will be required.

 

(b)
This Agreement shall terminate the earlier of
the following: (i) three (3) years as of the Closing; (ii) in connection with any Person that is a party hereto, whenever such
Person directly or indirectly owns less than 5% (five per cent) of the Fully Diluted Company Securities; or (iii) upon the consummation
of a Liquidation Event.

 

in
connection with the consummation of a Liquidation Event.

 

(c)
Notwithstanding the foregoing, any Person acquiring
5% (five per cent) or more of the Fully Diluted Company Securities may become a party to this Agreement as a “Management
Stockholder,” “Additional Stockholder” and “Stockholder” upon execution and delivery to the Company
of the form of Subscription and Joinder Agreement attached hereto as Exhibit C by such Person and the Company, at
which time Schedule A shall be amended to reflect the addition of such Stockholder.

 

    	 	17	 

    	 		 

    

 

SECTION
5.05. Fees and Expenses. Each party shall
pay its own costs and expenses incurred in connection with the preparation and execution of this Agreement and the Related Agreements.

 

SECTION
5.06. Governing Law. This Agreement shall
be governed by, and construed in accordance with, the laws of the State of Nevada, without regard to the conflicts of laws rules
of such state.

 

SECTION
5.07. Arbitration. Any and all claims
or controversies arising from or relating to, this Agreement, its interpretation, or its alleged breach or enforcement, shall
be resolved by binding arbitration before the American Arbitration Association (“AAA”) according to
the Commercial Arbitration Rules of the AAA then in effect (the “AAA Rules”). The arbitration shall occur in
New York, New York and the parties waive any objection to this choice of alternative dispute resolution, procedures or venue.
The parties shall each appoint a single arbitrator and such arbitrators shall agree upon a third arbitrator or, if no agreement
can be reached within fourteen (14) days after the AAA provides the list of names from its National Roster, the AAA shall appoint
the third arbitrator according to the AAA Rules then in effect. Any arbitration hereunder shall be conducted in English and shall
be completed within one hundred and eighty (180) days after appointment of the third arbitrator. The arbitrators shall be authorized
to award reasonable attorneys’ fees and costs to the prevailing party in the arbitration, and to include such sum in the
final arbitration award. The arbitrators may not award punitive, consequential or special damages. The arbitration award may be
confirmed as a judgment in any court having jurisdiction of the subject matter and parties.

 

SECTION
5.08. Waiver of Jury Trial. EACH OF THE
PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED
TO THIS AGREEMENT, THE RELATED AGREEMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY AND THEREBY.

 

SECTION
5.09. Specific Enforcement; Cumulative Remedies.
The parties hereto acknowledge that money damages may not be an adequate remedy for violations of this Agreement and that any
party, in addition to any other rights and remedies which the parties may have hereunder or at law or in equity, may, in his or
its sole discretion, apply to a court of competent jurisdiction for specific performance or injunction or such other relief as
such court may deem just and proper in order to enforce this Agreement or prevent any violation hereof and, to the extent permitted
by applicable law, each party waives any objection to the imposition of such relief. Process in any such suit, action or proceeding
may be served on any party anywhere in the world, whether within or without the jurisdiction of any such court. Without limiting
the foregoing, each party agrees that service of process on such party as provided in Section 5.03 shall be deemed effective
service of process on such party. All rights, powers and remedies provided under this Agreement or otherwise available in respect
hereof at law or in equity shall be cumulative and not alternative, and the exercise or beginning of the exercise of any thereof
by any party shall not preclude the simultaneous or later exercise of any other such rights, powers or remedies by such party.

 

    	 	18	 

    	 		 

    

 

SECTION
5.10. Entire Agreement. This Agreement
and any exhibits and other documents referred to herein constitute the entire agreement and understanding among the parties hereto
in respect of the subject matter hereof and thereof and supersede all prior and contemporaneous agreements and understandings,
both oral and written, among the parties hereto, or between any of them, with respect to the subject matter hereof and thereof.

 

SECTION
5.11. Spouses. This Agreement must be
executed by the spouse of each Stockholder who is a resident of a community property state (which, at the date hereof, are Arizona,
California, Idaho, Louisiana, Nevada, New Mexico, Puerto Rico, Texas, Washington or Wisconsin), or if married in a jurisdiction
outside of the United States of America, to the extent that such marriage is under a community property regime and spousal consent
to execute this Agreement would be necessary or convenient. By executing this Agreement, such spouse acknowledges that she or
he has read this Agreement and knows its contents and agrees to be bound in all respects by the terms of this Agreement to the
same extent as the Stockholders. Each such spouse further agrees that should she or he predecease the Stockholder to whom she
or he is married or should she or he become divorced from such Stockholder, any of the Company Securities which such spouse may
own or in which she or he may have any interest shall remain subject to all of the restrictions and to all of the rights of the
Stockholders contained in this Agreement.

 

SECTION
5.12. Severability. If any term, provision,
covenant or restriction of this Agreement is held by a court of competent jurisdiction or other authority to be invalid, void
or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force
and effect and shall in no way be affected, impaired or invalidated. Upon such a determination, the parties shall negotiate in
good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable
manner so that the transactions contemplated hereby be consummated as originally contemplated to the fullest extent possible.

 

SECTION
5.13. Counterparts; Effectiveness. This
Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, with the same effect
as if the signatures thereto and hereto were upon the same instrument. This Agreement will become effective when duly executed
and delivered by each party hereto. Counterpart signature pages to this Agreement may be delivered by facsimile or electronic
delivery (i.e., by email of a PDF signature page) and each such counterpart signature page will constitute an original
for all purposes.

 

    	 	19	 

    	 		 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the day and year first above written.

 

	 	ONCBIOMUNE PHARMACEUTICALS, INC.
	 	 	 
	 	By:	/s/
    Andrew Albert Kucharchuk
	 	Name:	Andrew
    Albert Kucharchuk
	 	Title:	President
    and CFO

 

[SIGNATURE
PAGE TO THE STOCKHOLDERS’ AGREEMENT]

 

    	 	20	 

    	 		 

    

 

	 	MANAGEMENT
    STOCKHOLDERS
	 	 
	 	/s/
    Jonathan F. Head, Ph.D.
	 	Jonathan
    F. Head, Ph.D.
	 	 
	 	/s/
    Andrew Albert Kucharchuk
	 	Andrew
    Albert Kucharchuk

 

[SIGNATURE
PAGE TO THE STOCKHOLDERS’ AGREEMENT]

 

    	 	21	 

    	 		 

    

 

	 	VITEL
    STOCKHOLDERS
	 	 
	 	/s/
    Manuel Cosme Odabachian
	 	Manuel
    Cosme Odabachian
	 	 
	 	/s/
    Carlos Fernando Alaman
	 	Carlos
    Fernando Alaman

 

[SIGNATURE
PAGE TO THE STOCKHOLDERS’ AGREEMENT]

 

    	 	22	 

    	 		 

    

 

Spouse’s
Agreement

 

The
undersigned, being the spouse of Jonathan F. Head, Ph.D. agrees to be bound by the provisions of this Agreement, to the extent
applicable to the undersigned.

 

	 	/s/
    Priscila T. Head
	 	Printed
    Name: Priscila T. Head

 

    	 	23	 

    	 		 

    

Spouse’s
Agreement

 

The
undersigned, being the spouse of Andrew Albert Kucharchuk agrees to be bound by the provisions of this Agreement, to the extent
applicable to the undersigned.

 

	 	/s/
    Jessica B. Kucharchuk
	 	Printed
    Name: Jessica B. Kucharchuk

 

    	 	24	 

    	 		 

    

 

SCHEDULE
A

MANAGEMENT AND ADDITIONAL STOCKHOLDERS

 

	 	 	 	 	 	 	 
	Management Stockholder	 	Common Stock1
	 	 	Preferred Stock	 
	 	 	 	 	 	 	 
	Jonathan F. Head, Ph.D.	 	 	16,926,078	 	 	 	500,000	 
	11441 Industriplex Blvd., Suite 190
 Baton Rouge, LA 70809
 email: jhead@oncbiomune.com	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	Andrew A. Kucharchuk	 	 	5,000,000	 	 	 	0	 
	11441 Industriplex Blvd., Suite 190
 Baton Rouge, LA 70809
 email: akucha1.obmp@gmail.com	 	 	 	 	 	 	 	 

 

 

1
Does not include options to purchase 2,000,000 shares of common stock issued to each of Messrs. Head and Kucharchuk on the
date of this Agreement.

 

    	 	25	 

    	 		 

    

 

EXHIBIT
C

 

JOINDER
TO STOCKHOLDERS’ AGREEMENT

 

This
Joinder Agreement (this “Joinder Agreement”) is made as of the date written below by the undersigned
(the “Joining Party”) in accordance with the Stockholders’ Agreement dated as of March 10, 2017
(the “Stockholders’ Agreement”) among OncBioMune Pharmaceuticals, Inc. and certain other persons
named therein, as the same may be amended from time to time. Capitalized terms used, but not defined, herein shall have the meaning
ascribed to such terms in the Stockholders’ Agreement.

 

The
Joining Party hereby acknowledges, agrees and confirms that, by its execution of this Joinder Agreement, the Joining Party shall
be deemed to be a party to and [“Management Stockholder”/”Vitel Stockholder”/”Additional Stockholder”]
under the Stockholders’ Agreement as of the date hereof and shall have all of the rights and obligations of the Stockholder
from whom it has acquired Company Securities (to the extent permitted by the Stockholders’ Agreement) as if it had executed
the Stockholders’ Agreement. The Joining Party hereby ratifies, as of the date hereof, and agrees to be bound by, all of
the terms, provisions and conditions contained in the Stockholders’ Agreement.

 

IN
WITNESS WHEREOF, the undersigned has executed this Joinder Agreement as of the date written below.

 

Date:
______ ___, 20[__]

 

	 	[NAME OF JOINING PARTY]
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 
	 	 	 
	 	Address for Notices:

 

AGREED
ON THIS [__] day of [__], 20[__]:

 

ONCBIOMUNE
PHARMACEUTICALS, INC.

 

	By:	 	 
	Name:	 	 
	Title:	 	 

 

    	 	26	 

    	 		 

    

 

EXHIBIT
D

 

MAJOR
DECISIONS

 

	 	(a)	Any
    authorization, increase, sale or issuance of any additional Company Securities, or options, warrants, securities convertible
    into or exercisable or exchangeable for ownership interests in the Company or similar rights to acquire any interest of any
    kind in the Company, including but not limited to the approvals in connection with Sections 4.01(c), 4.01(c)(i) and 4.01(e)
    of the Stockholders’ Agreement which this Exhibit forms part of; 
	 	 	 
	 	(b)	Making,
    cancelling or modifying any payment of dividends or other distributions of the Company; 
	 	 	 
	 	(c)	Redemption
    or repurchase of any of the Company Securities;
	 	 	 
	 	(d)	Any
    acquisition of substantially all of the assets or stock of another Person or the merger, consolidation, sale of all or substantially
    all of the assets of the Company or other business combination of the Company; including entering into any merger, spin-off,
    consolidation or other business combination or any other change of control transaction; 
	 	 	 
	 	(e)	Entering
    into debt obligations other than those contemplated in a current approved business plan and budget; 
	 	 	 
	 	(f)	Any
    amendment to the Bylaws of the Company that adversely impacts the parties to this Stockholders’ Agreement; 
	 	 	 
	 	(g)	Approval
    of the Company’s (consolidated with the Company Subsidiaries, in case of existence) annual budget, its business plans,
    as well as any material revision of such budget and/or business plans, and/or any material investment not contemplated in
    a then current budget or business plan. For purposes of this clause, the word “material” shall mean a revision
    or investment having an expected impact of 10% (ten percent) or more on the line item contained in the annual budget or business
    plan. 
	 	 	 
	 	(h)	Any
    authorization or approval of compensation packages paid to the Directors or the first level management of the Company or paid
    to employees of the Company whose annual compensation would exceed $100,000 (one hundred thousand Dollars 00/100). First level
    management compensation shall be approved by the Board of Directors. First level management in the Company shall include the
    CEO and all of his/her direct reports;
	 	 	 
	 	(i)	Any
    appointment, renewal and removal of first level management officers;
	 	 	 
	 	(j)	Selection,
    approval, ratification or change of the external auditors of the Company; 

 

    	 	27	 

    	 		 

    

 

	 	(k)	Any
    change in the size or composition of the Board of Directors; including the appointment, ratification or change in the President
    and/or the independent member(s) of the Board of Directors not otherwise contemplated by the Stockholders’ Agreement;
	 	 	 
	 	(l)	Any
    appointment, renewal, removal or change in the size or composition of any committees within the Board of Directors as well
    as its members; including any change in the delegated powers of any committees of the Board of Directors;
	 	 	 
	 	(m)	Any
    sale or disposition of any direct or indirect equity interest of the Company in any Subsidiary, as well as any sale or disposition
    of assets or property by the Company (other than sales of inventory in the ordinary course of business) in excess of $100,000
    (one hundred thousand Dollars 00/100) in any fiscal year;
	 	 	 
	 	(n)	Any
    changes in the commercial activity of the Company, or material alteration to the nature of the Company’s business or
    material expansion of the Company’s business, or corporate purpose of the Company; including material deviations in
    business strategy from what is contemplated in the currently approved Company business plan;
	 	 	 
	 	(o)	Except
    for transactions pursuant to contracts or agreements in existence as of the date hereof, any related party transaction, which
    includes transactions between the Company on the one side, and Stockholders or their Affiliates on the other;
	 	 	 
	 	(p)	Any
    contract, agreement or transaction to which the Company is a party by means of which the Company acquires rights or obligations
    for a term longer than one (1) year or whose value exceeds the amount of $100,000 (one hundred thousand Dollars 00/100), as
    well as any amendment, termination, cancellation or rescission thereof; provided that the Board by resolution may establish
    contract values that will not require prior Board approval;
	 	 	 
	 	(q)	Any
    action that effects or agrees to change or modify the accounting methods of the Company;
	 	 	 
	 	(r)	Approving
    the purchase and/or sale and/or the creation of any mortgage, lien or other form of encumbrance of any significantly material
    assets of the Company;
	 	 	 
	 	(s)	Any
    change to the Company’s capital structure that alters or modifies the rights, preferences or privileges of Company Securities,
    including the reclassification or recapitalization of the outstanding capital stock of the Company;
	 	 	 
	 	(t)	Any
    making, or receiving or repayment of Stockholder loans;
	 	 	 
	 	(u)	Any
    grant of any license to another Person of any of the Company’s trademarks, know-how or other intellectual property;
    and
	 	 	 
	 	(v)	Any
    authorization of an officer or Director of the Company to vote any shares of another Person held by the Company.

 

    	 	28	 

    	 		 

    

 

EXHIBIT
E

 

WRITTEN
CONSENTS OF THE BOARD OF DIRECTORS OF THE COMPANY

 

WRITTEN
CONSENT OF THE BOARD OF DIRECTORS

OF

ONCBIOMUNE
PHARMACEUTICALS, INC.

 

The
undersigned, being all of the members of the Board of Directors (the “Board”) of ONCBIOMUNE PHARMACEUTICALS,
INC., a Nevada corporation (the “Corporation”), do hereby consent that the resolutions set forth below shall
be deemed to have been adopted to the same extent and to have the same force and effect as if adopted at a formal meeting of the
Corporation’s Board of Directors at a meeting duly called and held for purposes of acting upon proposals to adopt such resolutions
(the “Written Consent”).

 

WHEREAS,
the Board of Directors deems it advisable and generally in the Corporation’s best interests to amend its Amended and Restated
Articles of Incorporation (the “Amendment to Articles”) to amend Article 4 to clarify certain limitations on
the rights on holders of the Corporation’s common stock, replace Article 8 to permit the Board to amend the Bylaws without
shareholder approval and adopt the form of Amendment to Articles attached hereto as Exhibit A.

 

WHEREAS,
the Board of Directors deems it advisable and generally in the Corporation’s best interest to amend and restate its Bylaws
and adopt the Amended and Restated Bylaws attached hereto as Exhibit B (the “Amended and Restated Bylaws”).

 

WHEREAS,
the Board of Directors deems it advisable and generally in the Corporation’s best interest to appoint a corporate secretary.

 

NOW,
THEREFORE, BE IT RESOLVED, that the Board of Directors hereby approves the Amendment to Articles and the Amended and Restated
Bylaws (collectively, the “Corporate Actions”); and be it

 

FURTHER
RESOLVED, that the Board of Directors be and hereby directs that the Corporate Actions be submitted to the shareholders of
the Corporation for their consideration and approval, and recommends that the Corporation’s shareholders approve the Corporate
Actions; and be it

 

FURTHER
RESOLVED, that the Corporation shall notify its shareholders of the Corporate Actions and approves of the officers of the
Corporation mailing or otherwise delivering, or causing the mailing or delivery of such notification to the shareholders of the
Corporation entitled to notice of the matters set forth in the Written Consent; and be it

 

FURTHER
RESOLVED, that the Board of Directors hereby ratifies and approves that the date of shareholder approval of the Corporate
Actions is hereby fixed as the record date as of which the holders of the outstanding shares of the Corporation’s Common
Stock shall be entitled to notice of the Written Consent; and be it

 

FURTHER
RESOLVED, at such time as a majority of the shareholders of the Corporation approve and adopt the Corporate Actions that the
proper officers of the Corporation be and hereby are authorized and directed to execute on the Corporation’s behalf the
Amendment to Articles, and to file such Amendment to Articles with the Secretary of State of Nevada with such effective date as
the President of the Corporation deems appropriate but in no event earlier than 20 days after the mailing of the Information Statement
to be filed by the Corporation with the Securities and Exchange Commission in accordance with the applicable rule of the Exchange
Act of 1934, as amended, and be it.

 

    	 	29	 

    	 		 

    

 

FURTHER
RESOLVED, that Andrew A. Kucharchuk, is hereby appointed as the corporate Secretary of the Corporation; and be it

 

FURTHER
RESOLVED,
that the proper officers of the Corporation be, and each of them hereby is, in accordance with the foregoing resolutions, authorized,
empowered and directed, in the name and on behalf of the Corporation, to prepare, execute and deliver, or cause to be prepared,
executed and delivered, any and all agreements, amendments, certificates, reports, applications, notices, instruments, schedules,
statements, consents, letters or other documents and information and to do or cause to be done any and all such other acts and
things as, in the opinion of any such officer, may be necessary, appropriate or desirable in order to enable the Corporation fully
and promptly to carry out the purposes and intent of the foregoing resolutions, to make any filings pursuant to federal, state
and foreign laws, and to take all other actions that he or she deems necessary, appropriate or advisable in order to comply with
the applicable laws and regulations of any jurisdiction (domestic or foreign), or otherwise to effectuate and carry out the purposes
of the foregoing resolutions and to permit the transactions contemplated thereby to be lawfully consummated, and any such action
taken or any agreements, amendments, certificates, reports, applications, notices, instruments, schedules, statements, consents,
letters or other documents and information executed and delivered by them or any of them in connection with any such action shall
be conclusive evidence of their or his or her authority to take, execute and deliver the same; and it is further

 

FURTHER
RESOLVED, that each of the proper officers of the Corporation is authorized and directed, in the name and on behalf of the
Corporation, to take or cause to be taken any and all such further actions and to prepare, execute and deliver or cause to be
prepared, executed and delivered all such further agreements, documents, certificates and undertakings, and to incur all such
fees and expenses, as in his or her judgment shall be necessary, appropriate or advisable to carry out and effectuate the purpose
and intent of any and all of the foregoing resolutions; and be it

 

FURTHER
RESOLVED, that all actions previously taken by any officer, director, representative or agent of the Corporation, in the name
or on behalf of the Corporation or any of its affiliates in connection with the transactions contemplated by the foregoing resolutions
be, and each of the same hereby is, adopted, ratified, confirmed and approved in all respects as the act and deed of the Corporation;
and be it

 

FURTHER
RESOLVED, that the Board hereby adopts, as if expressly set forth herein, the form of any and all resolutions required by
any authority to be filed in connection with any applications, reports, filings, consents to service of process, powers of attorney,
covenants and other papers, instruments and documents relating to the matters contemplated by the foregoing resolutions if (i)
in the opinion of a proper officer of the Corporation executing the same, the adoption of such resolutions is necessary or advisable,
and (ii) the secretary or an assistant secretary of the Corporation evidences such adoption by inserting with this written consent
copies of such resolutions, which will thereupon be deemed to be adopted by the Board with the same force and effect as if originally
set forth herein.

 

Dated:
March __, 2017

 

Board
of Directors:

 

		 	
	Jonathan
    F. Head, Ph. D., Director	 	Daniel
    S. Hoverman, Director
		 	
	Manuel
    Cosme Odabachian, Director	 	Charles
    L. Rice, Jr., Director

 

    	 	30	 

    	 		 

    

 

Exhibit
A

 

Amendment
to Amended and Restated Articles of Incorporation

 

ARTICLES
OF AMENDMENT TO

AMENDED
AND RESTATED ARTICLES OF INCORPORATION

OF

ONCBIOMUNE
PHARMACEUTICALS, INC.

 

Pursuant
to NRS 78.390 of the Nevada Revised Statutes (the “NRS”), ONCBIOMUNE PHARMACEUTICALS, INC., a Nevada corporation (the
“Corporation”), hereby amends its Amended and Restated Articles of Incorporation as follows:

 

1.
Amendments.

 

(a)
Article 4 – Capital Stock of the Corporation’s Amended and Restated Articles of Incorporation is hereby amended by
adding the following new Section 4.3:

 

Section
4.3 Rights of Holders of Common Stock. The following rights, powers, privileges and restrictions, qualifications, and limitations
apply to the Common Stock.

 

(a)
General. The voting, dividend and liquidation rights of the holders of the Common Stock are subject to and qualified by
the rights, powers and privileges of the holders of the Preferred Stock.

 

(b)
Voting. The holders of the Common Stock are entitled to one vote for each share of Common Stock held at all meetings of
stockholders (and written actions in lieu of meetings). Unless required by law, there shall be no cumulative voting. The number
of authorized shares of Common Stock may be increased or decreased (but not below the number of shares thereof then outstanding)
by (in addition to any vote of the holders of one or more series of Preferred Stock that may be authorized by the Board) the affirmative
vote of the holders of shares of capital stock of the Corporation representing a majority of the votes represented by all outstanding
shares of capital stock of the Corporation entitled to vote. Further, holders of the Common Stock shall have no right to vote
on the designations, preferences, limitations and relative or other rights of the Preferred Stock or any series thereof (collectively,
the “Preferences”), or on any amendment, alteration or repeal of the Preferences or the Preferred Stock, at any time,
whether before or after the issuance thereof.

 

(b)
Article 8 of the Corporation’s Amended and Restated Articles of Incorporation is hereby amended by replacing the existing
Article 8 in its entirety with the following new Article 8:

 

    	 	31	 

    	 		 

    

 

ARTICLE
8 – AMENDMENTS AND STOCKHOLDER ACTIONS

 

Section
8.1 Amendments. The Board of Directors, without the necessity of stockholder vote, shall have the authority to amend or repeal
these Amended and Restated Articles of Incorporation to the fullest extent allowable by the NRS.

 

Section
8.2 Stockholder Actions. Where a stockholder vote is required by the NRS, including, but not limited to (i) amendments
to these Amended and Restated Articles of Incorporation, (ii) sale of substantially all of its assets, or (iii) mergers, conversion
or exchanges, the affirmative vote of the holders of at least 60% of the votes of all stockholders of the Corporation who have
voting power, voting together as a single class, is required to amend or repeal these Articles of Incorporation.

 

The
Board may make, amend and repeal the Bylaws of the Corporation or adopt new Bylaws. Nothing herein shall deny the concurrent power
of the stockholders to adopt, alter, amend or repeal the Bylaws.

 

2.
Effective Date. The effective date of this amendment to the Amended and Restated Articles of Incorporation shall be the
close of business on the date of filing with Nevada Secretary of State.

 

3.
Adoption of Amendment.

 

(a)
The foregoing amendment to the Articles of Incorporation was approved by the Board of Directors of the Corporation by unanimous
written consent in lieu of meeting on March __, 2017.

 

(b)
The vote by which the stockholders holding shares in the Corporation entitling them to exercise at least a majority of the voting
power, or such greater proportion of the voting power as may be required in the case of a vote by classes or series, or as may
be required by the provisions of the Amended and Restated Articles of Incorporation have voted in favor of the amendment is: [___]%.

 

IN
WITNESS WHEREOF, the undersigned has executed these Articles of Amendment to Amended and Restated Articles of Incorporation
as of March, 2017.

 

	 	ONCBIOMUNE PHARMACEUTICALS, INC.
	 	 	 
	 	By:
    	 
	 	 	Jonathan
    F. Head, Ph.D., Chief Executive Officer

 

    	 	32	 

    	 		 

    

 

Exhibit
B

 

Amended
and Restated Bylaws

 

AMENDED
AND RESTATED BYLAWS

 

OF

 

ONCBIOMUNE
PHARMACEUTICALS, INC.,

 

a
Nevada corporation

 

Article
6 - OFFICES

 

The
registered office of the corporation shall be at such address as shall be set forth from time to time in the office of the Secretary
of State of Nevada.

 

The
corporation may also have offices at such other places both within and outside the State of Nevada as the Board of Directors may
from time to time determine or the business of the corporation may require.

 

Article
7 - BOARD OF DIRECTORS

 

SECTION
7.01. GENERAL POWERS

 

The
directors shall in all cases act as a Board. The business of the corporation shall be managed under the direction of its Board
of Directors, which may exercise all such powers of the corporation and do all such lawful acts and things as are not by statute
or by the articles of incorporation or by these bylaws directed or required to be exercised or done by the stockholders.

 

SECTION
7.02. NUMBER OF DIRECTORS

 

The
number of directors of the corporation shall be fixed from time to time by a resolution adopted by the Board; provided that in
no event shall the number of directors be less than one, and provided further that no reduction in the number of directors shall
have the effect of shortening the term of any incumbent director.

 

SECTION
7.03. TERM OF OFFICE; qUALIFICATIONS

 

The
directors shall be elected at the annual meeting of the stockholders, and each director shall hold office until the next annual
meeting of stockholders and until his or her successor shall have been elected and qualified.

 

Only
persons who are nominated in accordance with the following procedures shall be eligible for election as directors of the corporation,
except as may be otherwise provided in the articles of incorporation. Nominations of persons for election to the Board of Directors
may be made at any annual meeting of stockholders, or at any special meeting of stockholders called for the purpose of electing
directors, (a) by or at the direction of the Board of Directors (or any duly authorized committee thereof) or (b) by any stockholder
of the corporation (i) who is a stockholder of record on the date of the giving of the notice provided for in this Section 3 of
Article II and on the record date for the determination of stockholders entitled to vote at such meeting and (ii) who complies
with the notice procedures set forth in this Section 3 of Article II.

 

In
addition to any other applicable requirements, for a nomination to be made by a stockholder, such stockholder must have given
timely notice thereof in proper written form to the secretary of the corporation. To be timely, a stockholder’s notice to
the secretary must be delivered to or mailed and received at the principal executive offices of the corporation (a) in the case
of an annual meeting, not less than 60 days nor more than 90 days prior to the anniversary date of the immediately preceding annual
meeting of stockholders; provided, however, that in the event that the annual meeting is called for a date that is not within
30 days before or after such anniversary date, notice by the stockholder in order to be timely must be so received not later than
the close of business on the 10th day following the day on which such notice of the date of the annual meeting was
mailed or such public disclosure of the date of the annual meeting was made, whichever first occurs; and (b) in the case of a
special meeting of stockholders called for the purpose of electing directors, not later than the close of business on the 10th
day following the day on which notice of the date of the special meeting was mailed or public disclosure of the date of
the special meeting was made, whichever first occurs. Public disclosure shall have the meaning set forth in Article IV, Section
13 herein.

 

    	 	33	 

    	 		 

    

 

To
be in proper written form, a stockholder’s notice to the secretary must set forth (a) as to each person whom the stockholder
proposes to nominate for election as a director (i) the name, age, business address and residence address of the person, (ii)
the principal occupation or employment of the person, (iii) the class or series and number of shares of capital stock of the corporation
which are owned beneficially or of record by the person and (iv) any other information relating to the person that would be required
to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for election
of directors pursuant to Section 14 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the
rules and regulations promulgated thereunder; and (b) as to the stockholder giving the notice (i) the name and record address
of such stockholder, (ii) the class or series and number of shares of capital stock of the corporation which are owned beneficially
or of record by such stockholder, (iii) a description of all arrangements or understandings between such stockholder and each
proposed nominee and any other person or persons (including their names) pursuant to which the nomination(s) are to be made by
such stockholder, (iv) a representation that such stockholder intends to appear in person or by proxy at the meeting to nominate
the persons named in its notice and (v) any other information relating to such stockholder that would be required to be disclosed
in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors
pursuant to Section 14 of the Exchange Act and the rules and regulations promulgated thereunder. Such notice must be accompanied
by a written consent of each proposed nominee to being named as a nominee and to serve as a director if elected.

 

No
person shall be eligible for election as a director of the corporation unless nominated in accordance with the procedures set
forth in this Section 3 of Article II. If the chairman of the meeting determines that a nomination was not made in accordance
with the foregoing procedures, the chairman shall declare to the meeting that the nomination was defective and such defective
nomination shall be disregarded.

 

SECTION
7.04. VACANCIES

 

Vacancies
and newly created directorships resulting from any increase in the authorized number of directors may be filled by a majority
of the directors then in office, and the directors so chosen shall hold office until the next annual election and until their
successors are duly elected and qualified. If there are no directors in office, then an election of directors may be held in the
manner provided by statute.

 

SECTION
7.05. MEETINGS OF THE BOARD

 

A
regular meeting of the directors shall be held at the principal offices of the corporation or at such other place and at such
date and time as may be fixed by resolution of the Board. No notice need be given for regularly scheduled meetings of the Board
as set up in the resolutions called for above. An annual meeting of the Board may be called without notice immediately after the
annual meeting of the stockholders. Special meetings may be held at the request of the president, vice president, secretary or
any two directors by giving written notice not less than 24 hours before the meeting. Notice must include the date, time and place
of any such meeting and be served to each director via personal delivery, facsimile, email or overnight courier. Any such notice
shall be deemed to have been given as of the date so personally delivered, sent via facsimile transmission or sent via email or
as of the day following dispatch by overnight courier. The attendance of a director at a meeting constitutes a waiver of notice
of such meeting, unless the express purpose of a director’s attendance is to protest, before or at the commencement of said
meeting, the transaction of any business because the meeting is not lawfully called or convened.

 

    	 	34	 

    	 		 

    

 

SECTION
7.06. COMMITTEES

 

The
Board of Directors may designate an executive committee and one or more other committees, each committee to consist of one of
more directors of the corporation. Any such committee, to the extent provided in any such resolution, shall have and may exercise
all the powers and authority of the Board in the management of the business and affairs of the corporation. Any such committee
shall keep written minutes of its meetings and report the same to the Board at the next regular meeting of the Board. In the absence
or disqualification of a member of a committee, the member or members thereof present at any meeting and disqualified from voting,
whether or not he, she or they constitute a quorum, may unanimously appoint another member of the Board to act at the meeting
in the place of any such absent or disqualified member. Each such committee shall serve at the pleasure of the Board of Directors.

 

SECTION
7.07. QUORUM

 

A
majority of the directors then in office shall constitute a quorum for the transaction of business at any meeting of the Board
of Directors, provided, that the directors present at a meeting at which a quorum is initially present may continue to transact
business notwithstanding the withdrawal of directors if any action taken is approved by a majority of the required quorum for
such meeting. If less than a majority of the Board is present at a meeting, a majority of the directors present may adjourn the
meeting without further notice, from time to time.

 

SECTION
7.08. PARTICIPATION BY CONFERENCE CALL

 

The
members of the Board of Directors or of any committee commissioned by the Board may participate in and be counted present at any
such meeting at which contact is made via video conference system, a conference telephone or similar communications equipment
where, by the use of such equipment, all persons participating in any such meeting can hear each other at the same time.

 

SECTION
7.09. BOARD DECISIONS

 

Unless
a vote of a greater number is required by the laws of the State of Nevada, the articles of incorporation, or these bylaws, the
affirmative vote of a majority of the directors present at a meeting at which a quorum is present shall be the act of the Board
of Directors.

 

SECTION
7.10. CHAIRMAN

 

The
Board of Directors may, from their number, elect a chairman of the Board who shall preside at all meetings of the Board and stockholders
and may have such additional responsibilities and powers as may from time to time be vested in him by resolution of the Board.

 

SECTION
7.11. VICE CHAIRMAN

 

The
Board of Directors may, from their number, elect a vice chairman of the board who shall perform the duties and have the powers
as the Board may from time to time designate. In the absence of the chairman of the board or if he or she is unable or unwilling
to perform his or her duties, the vice chairman of the board shall assume the duties and responsibilities of the chairman of the
board.

 

SECTION
7.12. COMPENSATION

 

The
directors shall receive only such compensation for their services as directors as may be allowed by resolution of the Board. The
Board may also provide that the corporation shall reimburse each such director for any expense incurred by such director on account
of such director’s attendance at any meetings of the Board or committees of the Board. Neither the payment of such compensation
nor the reimbursement of such expenses shall be construed to preclude any director from serving the corporation or its subsidiaries
in any other capacity and receiving compensation therefor.

 

    	 	35	 

    	 		 

    

 

 

SECTION
7.13. WRITTEN CONSENT TO ACTION BY DIRECTORS

 

Any
action required to be taken at a meeting of the directors of the corporation or any other action which may be taken at a meeting
of the directors or of a committee, may be taken without a meeting, if a consent in writing, setting forth the action so taken,
shall be signed by all of the directors, or all of the members of the committee, as the case may be, then in office. Such consent
shall have the same legal effect as a unanimous vote of all the directors or members of the committee.

 

Article
8 - OFFICERS

 

SECTION
8.01. NUMBER; TERM

 

The
officers of the corporation shall each be elected by the Board of Directors and shall be a president, a treasurer and a secretary.
The Board, as it deems necessary, may from time to time elect one or more vice presidents, assistant treasurers, assistant secretaries
and such other officers as it sees fit. Any person may hold two or more offices.

 

The
officers shall hold their offices for such terms and shall exercise such powers and perform such duties as shall be determined
from time to time by the Board. Any officer may be removed at any time by the affirmative vote of a majority of the directors
then in office. If the office of any officer becomes vacant for any reason, the vacancy shall be filled by the Board of Directors.

 

SECTION
8.02. RESIGNATION

 

Any
officer may resign at any time by delivering a written resignation to the Board of Directors, the president or the secretary.
Unless otherwise specified therein, such resignation shall take effect upon delivery.

 

SECTION
8.03. PRESIDENT

 

The
president shall be the chief executive officer of the corporation and, unless otherwise determined by resolution of the Board
of Directors, have charge and control of the business and affairs of the corporation. In the absence of a chairman and vice chairman
of the board, the president shall, when present, preside over all stockholders’ meetings. The president shall perform all
duties incident to the office of president and such other duties as may from time to time be designated by the Board.

 

SECTION
8.04. VICE PRESIDENT

 

Each
vice president shall perform the duties and have the powers as the Board of Directors may from time to time designate. In the
absence of the president or if such person is unable or unwilling to perform his duties the vice president, if only one, or such
vice president, if more than one, who is so designated by the Board will assume the duties and responsibilities of the president.

 

SECTION
8.05. TREASURER

 

The
treasurer shall have charge and custody of, and be responsible for, all funds and securities of the corporation; keep full and
accurate accounts of receipts and disbursements in books belonging to the corporation; receive and give receipts for monies due
and payable to the corporation from any source whatsoever, and shall deposit all monies and valuable effects in the name and to
the credit of the corporation in such banks and other depositories as shall be authorized by the Board of Directors.

 

If
required by the Board the treasurer shall give a bond for the faithful discharge of his duties in such amount and with such surety
as the Board shall determine. The treasurer shall perform all duties as stated above in addition to any additional duties or powers
as the Board may from time to time so designate to him.

 

    	 	36	 

    	 		 

    

 

SECTION
8.06. ASSISTANT TREASURER

 

Each
assistant treasurer shall perform the duties and have the powers as the Board of Directors may from time to time designate. In
the absence of the treasurer or if such person is unable or unwilling to perform his duties the assistant treasurer, if only one,
or such assistant treasurer, if more than one, who is so designated by the Board will assume the duties and responsibilities of
the treasurer.

 

SECTION
8.07. SECRETARY

 

The
secretary shall record in books kept for the purpose all votes and proceedings of the Board and the stockholders. Unless the Board
of Directors shall appoint a transfer agent and/or registrar or other officer or officers for the purpose, subject to such other
and different rules and guidelines as may be adopted from time to time by the Board of Directors, the secretary shall be charged
with the duty of keeping, or causing to be kept accurate records of all stock outstanding, stock certificates issued, and stock
transfers. All such records may be kept solely in the stock certificate books. The secretary shall also perform other duties and
have other powers as the Board of Directors may from time to time designate.

 

SECTION
8.08. ASSISTANT secretary

 

Each
assistant secretary shall perform the duties and have the powers as the Board of Directors may from time to time designate. In
the absence of the secretary or if such person is unable or unwilling to perform his duties the assistant secretary, if only one,
or such assistant secretary, if more than one, who is so designated by the Board will assume the duties and responsibilities of
the secretary.

 

SECTION
8.09. ABSENCE

 

In
the absence of the secretary or assistant secretary at any meeting of the stockholders, a secretary shall be chosen by the chairman
of the meeting to perform the duties of the secretary thereat.

 

Article
9- STOCKHOLDERS

 

SECTION
9.01. ANNUAL MEETING

 

Annual
meetings of the stockholders shall be held on the day and at the time as may be set by the Board of Directors from time to time
and as indicated in the notice of such meeting. At the annual meeting, the stockholders shall elect by vote a Board of Directors
and transact such other business as may properly be brought before the meeting.

 

SECTION
9.02. SPECIAL MEETINGS

 

Special
meetings of the stockholders for any purpose or purposes, unless otherwise prescribed by statute or by the articles of incorporation,
may be called by the Board of Directors, by a director, or by the president and shall be called by the secretary, or in the event
of his absence, incapacity, refusal or death, any other officer of the corporation, upon written request of one or more stockholders
owning at least 60% of all the shares issued and outstanding and entitled to vote. Such request shall be delivered to the president
of the corporation and shall state the purpose or purposes of the proposed meeting. Upon such direction or request, a special
meeting of the stockholders must be held not less than 10 nor more than 60 days thereafter, as the secretary may fix. If the secretary
shall neglect to issue such call, the person or persons making such direction or request may issue the call. The business transacted
at any special meeting of stockholders shall be confined to the purposes stated in the notice.

 

SECTION
9.03. PLACE OF MEETINGS

 

All
annual and special meetings of the stockholders shall be held at the corporation’s principal offices or at another place
within or outside the State of Nevada as designated by the Board of Directors.

 

    	 	37	 

    	 		 

    

 

SECTION
9.04. NOTICE OF MEETING

 

Written
notice of the time, date and place of every meeting of stockholders shall be given by the secretary or by any other officer of
the corporation designated by the directors or by these bylaws, not less than 10 calendar days prior to the meeting and not more
than 60 calendar days before the meeting, to each stockholder entitled to vote at such meeting. Notice must be served to each
stockholder entitled to vote via personal delivery, telegraph or mail addressed to that stockholder at his address as it appears
in the records of the corporation. The notice of a special meeting shall include a description of the purpose or purposes for
which the meeting is called.

 

SECTION
9.05. WAIVER OF NOTICE

 

Any
stockholder may waive notice of any meeting of stockholders (however called or noticed, whether or not called or noticed, and
whether before, during or after the meeting) by signing a written waiver of notice or a consent to the holding of such meeting
or an approval of the minutes thereof. Attendance at a meeting, in person or by proxy, shall constitute waiver of all defects
of notice regardless of whether a waiver, consent or approval is signed or any objections are made, unless attendance is solely
for the purpose of objecting at the beginning of the meeting to the transaction of any business because the meeting is not lawfully
called or convened. All such waivers, consents or approvals shall be made a part of the minutes of the meeting.

 

SECTION
9.06. CHAIRMAN OF MEETING

 

The
following individual is entitled to preside as chairman at a meeting of stockholders:

 

	(a)	the
    chairman of the board, if any;
	 	 
	(b)	if
    the chairman of the board is absent or unwilling to act as chairman of the meeting, the vice chairman of the board, if any;
	 	 
	(c)	if
    the chairman and vice chairman of the board are absent or unwilling to act as chairman of the meeting, the president, if any.

 

If,
at any meeting of stockholders, there is no chairman or vice chairman of the board or president present within 15 minutes after
the time set for holding the meeting, or if the chairman and vice chairman of the board and the president are unwilling to act
as chairman of the meeting, or if the chairman and vice chairman of the board and the president have advised the secretary, if
any, or any director present at the meeting, that they will not be present at the meeting, the directors present must choose one
of their number to be chairman of the meeting or if all of the directors present decline to take the chairman or fail to so choose
or if no director is present, the stockholders entitled to vote at the meeting who are present in person or by proxy may choose
any person present at the meeting to chair the meeting.

 

SECTION
9.07. CLOSING OF THE TRANSFER BOOKS

 

The
Board of Directors of the corporation may in its discretion fix a date not less than 10 calendar days and not more than 60 calendar
days prior to the date of any annual meeting or special meeting of the stockholders or prior to the payment of any dividend or
the making of any other distribution as the record date for determining the stockholders having the right to notice of, and to
vote at such meeting or any adjournment thereof, or the right to receive such distribution or dividend. In lieu of fixing such
closing date the directors may order the closing of the stock transfer books for a stated period not to exceed, in any case, 60
calendar days for the expressed purposes stated above. If no record date is fixed and the transfer records are not closed, the
record date for determining stockholders entitled to vote at any meeting to elect directors shall be determined as the close of
business on the day next preceding the date of notice of the meeting and, for a meeting for any other purpose, shall be determined
as the close of business on the day on which the Board acts with respect thereto.

 

    	 	38	 

    	 		 

    

 

The
holders of record of shares of the corporation on such record date or on the date of closing of the stock transfer books shall,
if a dividend or distribution be declared, have the sole right to receive such distribution or dividend, or, if such shares have
a voting right, the sole right to receive notice of, to vote at, and to attend such meeting.

 

SECTION
9.08. VOTING LISTS

 

The
officers of the corporation shall cause to be prepared from the stock ledger, at least 10 days before every meeting of stockholders,
a complete list of the stockholders entitled to vote at such meeting or any adjournment thereof, arranged in alphabetical order,
and showing the address of each stockholder and the number of shares registered in the name of each stockholder. Such list shall
be open to the examination of any stockholder, for any purpose germane to the meeting, during ordinary business hours, for a period
of at least 10 days prior to the meeting, either at a place within the city where the meeting is to be held, which place shall
be specified in the notice of the meeting, or, if not so specified, at the registered office of the corporation. The list shall
also be produced and kept at the time and place of the meeting during the whole time thereof and may be inspected by any stockholder
who is present. The original stock ledger shall be the only evidence as to who are the stockholders entitled to examine the stock
ledger, the list required by this section, or the books of the corporation, or to vote in person or by proxy at any meeting of
stockholders.

 

SECTION
9.09. VOTING

 

When
a quorum is present at any meeting, the vote of the holders of stock having at least 60% of the votes of all stockholders of the
Corporation who have voting power present in person or represented by proxy shall decide any question brought before such meeting,
unless the question is one on which by express provision of the statutes of the state of Nevada or of the articles of incorporation
a greater vote is required, in which case such express provision shall govern and control the decision of such question.

 

Unless
otherwise provided in the articles of incorporation, each stockholder shall at every meeting of the stockholders be entitled to
one vote in person or by proxy for each share of the capital stock having voting power held by such stockholder, subject to the
modification of such voting rights of any class or classes of the corporation’s capital stock by the articles of incorporation.

 

SECTION
9.10. PROXY VOTING

 

At
all meetings of the stockholders, a stockholder may vote by proxy executed in writing by the stockholder or by his duly authorized
attorney-in-fact. Such proxy must be filed with the secretary of the corporation before or at the time of the meeting. No proxy
dated more than six months before the meeting named therein shall be accepted, and no such proxy shall be valid after the adjournment
of such meeting except if such proxy is coupled with an interest as determined by applicable law. A proxy coupled with an interest
may be irrevocable if it so provides and shall be valid and enforceable until the interest terminates or for such shorter period
of time as the proxy provides.

 

SECTION
9.11. ACTION by consent

 

Any
action permitted or required at any stockholders meeting, including the election of directors, may be taken without a meeting,
unless otherwise provided by law, if a consent in writing is signed by the holders of outstanding stock having not less than the
minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to
vote thereon were present and voted. Prompt notice of the taking of the corporate action without a meeting by less than unanimous
written consent shall be given to those stockholders who have not consented in writing.

 

SECTION
9.12. QUORUM; ADJOURNMENT

 

Stock
representing at least 60% of the voting power of all outstanding stock of the corporation entitled to vote, present in person
or represented by proxy, shall constitute a quorum at all meetings of the stockholders for the transaction of business, except
as otherwise provided by statute or by the articles of incorporation. If, however, such quorum shall not be present or represented
at any meeting of the stockholders, the stockholders entitled to vote thereat, present in person or represented by proxy, shall
have power to adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum shall
be present or represented. At such reconvened meeting at which a quorum is present or represented, any business may be transacted
which might have been transacted at the meeting as originally notified. If the adjournment is for more than 30 days or if after
the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each
stockholder of record entitled to vote at the meeting.

 

    	 	39	 

    	 		 

    

 

SECTION
9.13. NOTICE OF STOCKHOLDER BUSINESS AT ANNUAL
MEETINGS

 

At
any annual meeting of stockholders, only such business shall be conducted as shall have been properly brought before the meeting.
In addition to any other requirements imposed by or pursuant to law, the articles of incorporation or these bylaws, each item
of business to be properly brought before an annual meeting must (a) be specified in the notice of meeting (or any supplement
thereto) given by or at the direction of the Board or the persons calling the meeting pursuant to the articles of incorporation;
(b) be otherwise properly brought before the meeting by or at the direction of the Board; or (c) be otherwise properly brought
before the meeting by a stockholder. For business to be properly brought before an annual meeting by a stockholder, the stockholder
must have given timely notice thereof in writing to the secretary of the corporation. To be timely, a stockholder’s notice
to the secretary must be delivered to or mailed and received at the principal executive offices of the corporation not less than
60 days nor more than 90 days prior to the anniversary date of the immediately preceding annual meeting of stockholders; provided,
however, that in the event that the annual meeting is called for a date that is not within 30 days before or after such anniversary
date, notice by the stockholder in order to be timely must be so received not later than the close of business on the 10th
day following the day on which such notice of the date of the annual meeting was mailed or such public disclosure of the
date of the annual meeting was made, whichever first occurs. Public disclosure of an adjournment or postponement of an annual
meeting shall not commence a new time period (or extend any time period) for the giving of a stockholder’s notice. For purposes
of these by laws “public disclosure” shall mean disclosure in a press release reported by the Dow Jones, Associated
Press, Reuters or comparable national news service, or in a document publicly filed by the corporation with the Securities and
Exchange Commission. To be in proper written form, a stockholder’s notice to the secretary must set forth as to each matter
such stockholder proposes to bring before the annual meeting (i) a brief description of the business desired to be brought before
the annual meeting and the reasons for conducting such business at the annual meeting, (ii) the name and record address of such
stockholder, (iii) the class or series and number of shares of capital stock of the corporation which are owned beneficially or
of record by such stockholder, (iv) a description of all arrangements or understandings between such stockholder and any other
person or persons (including their names) in connection with the proposal of such business by such stockholder and any material
interest of such stockholder in such business, and (v) a representation that such stockholder intends to appear in person or by
proxy at the annual meeting to bring such business before the meeting.

 

SECTION
9.14. INSPECTOR OF ELECTION

 

There
shall be appointed at least one inspector of the vote for each stockholders’ meeting. Such inspector(s) shall first take
and subscribe an oath or affirmation faithfully to execute the duties of inspector at such meeting with strict impartiality and
according to the best of their ability. Unless appointed in advance of any such meeting by the Board of Directors, such inspector(s)
shall be appointed for the meeting by the presiding officer. No director or candidate for the office of director shall be appointed
as such inspector. Such inspector(s) shall be responsible for tallying and certifying each vote required to be tallied and certified
by them as provided in the resolution of the Board of Directors appointing them or in their appointment by the person presiding
at such meeting, as the case may be.

 

    	 	40	 

    	 		 

    

 

Article
10 - STOCK CERTIFICATES

 

SECTION
10.01. SHARE CERTIFICATES

 

The
shares of the corporation shall be represented by certificates in such form as the appropriate officers of the corporation may
from time to time prescribe; provided that the Board may provide by resolution or resolutions that some or all of any or all classes
or series of stock of the corporation shall be uncertificated shares. Notwithstanding the foregoing, every holder of uncertificated
shares of a class or series some but not all of which are represented by certificates, shall be entitled, upon request, to a certificate
representing such shares. Every holder of uncertificated shares shall be entitled to receive a statement of holdings as evidence
of share ownership. Shares represented by certificates shall be numbered and registered in a share register as they are issued.
Share certificates shall exhibit the name of the registered holder, the number and class of shares and the series, if any, represented
thereby, the par value of each share or a statement that such shares are without par value as the case may be, and any other information
required by law, regulation or stock exchange rule. Except as otherwise expressly provided by law, the rights and obligations
of the holders of uncertificated shares and the rights and obligations of the holders of certificated shares of the same class
and series shall be identical.

 

SECTION
10.02. LOST OR DESTROYED CERTIFICATES

 

Lost,
mutilated, or destroyed certificates may be replaced by the issue of a new certificate upon such terms and indemnity to the corporation
as the Board may determine. The Board may as it sees fit require the owner or owner’s representative to give a bond to the
corporation with or without surety against any loss or claim which may arise from the issue of replacement certificate or certificates.

 

SECTION
10.03. SHARE TRANSFERS

 

Upon
surrender to the corporation, or a transfer agent of the corporation, of a certificate for shares duly endorsed or accompanied
by proper evidence of succession, assignment or authority to transfer, the corporation may issue to the person entitled thereto
(a) a new certificate for such shares or (b) if requested by the holder and such shares are of a class or series of stock which
may be uncertificated, (i) evidence of equivalent uncertificated shares or (ii) both a new certificate and evidence of uncertificated
shares equaling in the aggregate the number of shares represented by the surrendered certificate, and in any case, the corporation
shall cancel the old certificate and record the transaction upon its books. Upon receipt by the corporation, or a transfer agent
of the corporation, of proper transfer instructions for uncertificated shares, accompanied by proper evidence of succession, assignment
or authority to transfer, the corporation may issue to the person entitled thereto (a) evidence of equivalent uncertificated shares
or (b) if requested by the holder, (i) a certificate for such shares or (ii) both a certificate and evidence of uncertificated
shares equaling in the aggregate the number of shares covered by such transfer instructions, and in any case, the corporation
shall cancel the old uncertificated shares and record the transaction upon its books.

 

SECTION
10.04. transfer agents
and registrars

 

The
Board may appoint one or more transfer agents and one or more registrars (any one of which may be appointed as both transfer agent
and registrar) and may require all certificates for shares to bear the signature or signatures of any of them, any of which signature
or signatures may be facsimile. In case any officer or officers of the corporation who have signed, or whose facsimile signature
or signatures have been used on, any such certificate or certificates shall cease to be such officer or officers, whether because
of death, resignation or otherwise, before such certificate or certificates have been delivered by the corporation, such certificate
or certificates may, nevertheless, be issued and delivered as though the person or persons who signed such certificate or certificates
or whose facsimile signature or signatures have been used thereon had not ceased to be such officer or officers of the corporation.

 

    	 	41	 

    	 		 

    

 

 

Article
11 - INSURANCE AND OFFICER AND DIRECTOR CONTRACTS

 

SECTION
11.01. Indemnification:
Third-Party Actions.

 

The
corporation shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending, or
completed action, suit, or proceeding, whether civil, criminal, administrative, or investigative (other than an action by or in
the right of the corporation), by reason of the fact that such person is or was a director, officer, employee, or agent of the
corporation or is or was serving at the request of the corporation as a director, officer, employee, or agent of another corporation,
partnership, joint venture, trust, or other enterprise (an “Indemnified Person”), against expenses (including attorneys’
fees), judgments, fines, and amounts paid in settlement actually and reasonably incurred by him in connection with any such action,
suit, or proceeding, if such Indemnified Person acted in good faith and in a manner which such person reasonably believed to be
in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable
cause to believe his conduct was unlawful. The termination of any action, suit, or proceeding by judgment, order, settlement,
conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did
not act in good faith and in a manner which such person reasonably believed to be in or not opposed to the best interests of the
corporation, or, with respect to any criminal action or proceeding, such person had reasonable cause to believe that his conduct
was unlawful.

 

SECTION
11.02. Indemnification:
Corporate Actions.

 

The
corporation shall indemnify any Indemnified Person who was or is a party or is threatened to be made a party to any threatened,
pending, or completed action or suit by or in the right of the corporation to procure a judgment in its favor, against expenses
(including attorneys’ fees) actually and reasonably incurred by him in connection with the defense or settlement of such
action or suit, if such Indemnified Person acted in good faith and in a manner which such person reasonably believed to be in
or not opposed to the best interests of the corporation, except that no indemnification shall be made in respect of any claim,
issue, or matter as to which such person shall have been adjudged by a court of competent jurisdiction, after exhaustion of all
appeals therefrom, to be liable to the corporation or for amounts paid in settlement to the corporation, unless and only to the
extent that the court in which such action r suit was brought or other court of competent jurisdiction shall determine upon application
that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably
entitled to indemnity for such expenses as the court deems proper.

 

SECTION
11.03. Determination.

 

To
the extent that an Indemnified Person has been successful on the merits or otherwise in defense of any action, suit, or proceeding
referred to in Article VI, Sections 1 and 2 hereof, or in defense of any claim, issue, or matter therein, such Indemnified Person
shall be indemnified against expenses (including attorneys’ fees) actually and reasonably incurred by such person in connection
therewith. Any other indemnification under Article VI, Sections 1 or 2 hereof, unless ordered by a court, shall be made by the
corporation only in a specific case in which a determination is made that indemnification of the Indemnified Person is proper
in the circumstances because such person has met the applicable standard or conduct set forth in Article VI, Sections 1 or 2 hereof.
Such determination shall be made either (i) by the Board of Directors by a majority vote of a quorum consisting of directors who
were not parties to such action, suit, or proceeding, (ii) if such a quorum is not obtainable, or, even if obtainable, a quorum
of disinterested directors so directs, by independent legal counsel in a written opinion, or (iii) by the stockholders by a majority
vote of a quorum of stockholders at any meeting duly called for such purpose.

 

    	 	42	 

    	 		 

    

 

SECTION
11.04. Advances.

 

Expenses
incurred by an Indemnified Person in defending a civil or criminal action, suit, or proceeding shall be paid by the corporation
in advance of the final disposition of such action, suit, or proceeding on receipt of an undertaking by or on behalf of such Indemnified
Person to repay such amount if it shall ultimately be determined that such Indemnified Person is not entitled to be indemnified
by the corporation as authorized by this section.

 

SECTION
11.05. Scope of Indemnification.

 

The
indemnification and advancement of expenses provided by, or granted pursuant to, Article VI, Sections 1, 2 and 4:

 

(a)
Shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled,
under any bylaw, agreement, vote of stockholders or disinterested directors, or otherwise, both as to action in his official capacity
and as to action in another capacity while holding such office; and

 

(b)
Shall, unless otherwise provided when authorized or ratified, continue as to a person who ceases to be an Indemnified Person and
shall inure to the benefit of the heirs, executors, and administrators of such Indemnified Person.

 

SECTION
11.06. Insurance.

 

The
corporation may purchase and maintain insurance on behalf of any person who is or was an Indemnified Person against any liability
asserted against and incurred by such Indemnified Person in any such capacity or arising out of the Indemnified Person’s
status as such, whether or not the corporation would have the power to indemnify the Indemnified Person against any such liability.

 

SECTION
11.07. Officer and
Director Contracts.

 

No
contract or other transaction between the corporation and one or more of its directors or officers or between the corporation
and any corporation, partnership, association, or other organization in which one or more of the corporation’s directors
or officers are directors, officers, or have a financial interest, is either void or voidable solely on the basis of such relationship
or solely because any such director or officer is present at or participates in the meeting of the Board of Directors or a committee
thereof which authorizes the contract or transaction or solely because the vote or votes of each director or officer are counted
for such purpose, if:

 

(a)
The material facts of the relationship or interest are disclosed or known to the Board of Directors or committee and the Board
or committee in good faith authorizes the contract or transaction by the affirmative votes of a majority of the disinterested
directors even though the disinterested directors be less than a quorum;

 

(b)
The material facts of the relationship or interest is disclosed or known to the stockholders and they approve or ratify the contract
or transaction in good faith by a majority vote of the shares voted at a meeting of stockholders called for such purpose or written
consent of stockholders holding a majority of the shares entitled to vote (the votes of the common or interested directors or
officers shall be counted in any such vote of stockholders); or

 

(c)
The contract or transaction is fair as to the corporation at the time it is authorized, approved, or ratified by the Board of
Directors, a committee thereof, or the stockholders.

 

    	 	43	 

    	 		 

    

 

Article
12 - FISCAL YEAR

 

The
fiscal year of the corporation shall be fixed by resolution of the Board.

 

Article
13 - DIVIDENDS

 

The
Board of Directors may from time to time declare, and the corporation may pay, dividends on its outstanding stock in the manner
and on the terms and conditions provided by the articles of incorporation and bylaws.

 

Article
14 - SEAL

 

The
corporation may or may not have a corporate seal, as may from time to time be determined by the Board of Directors. If a corporate
seal is adopted, it shall be circular in form and shall be inscribed with the name of the corporation as it appears on the articles
of incorporation, the state of incorporation and the year of incorporation. The secretary shall have custody of the seal and may
affix it to any instrument requiring the corporate seal, as may any other officer of the corporation if so authorized by the Board
of Directors.

 

Article
15 - Acquisition of
Controlling Interest

 

The
corporation elects not to be governed by NRS 78.378 to 78.3793, inclusive.

 

Article
16 - Combinations with
InterestED Stockholders

 

The
corporation elects not to be governed by NRS 78.411 to 78.444, inclusive.

 

Article
17 - AMENDMENTS

 

All
bylaws of the corporation may be amended, altered or repealed, and new bylaws may be made, by the affirmative vote of a majority
of the directors cast at any regular or special meeting at which a quorum is present provided that such authority has been delegated
to the Board of Directors by the articles of incorporation.

 

Article
18 - PROVISIONS OF LAW

 

The
provisions of these bylaws shall be controlled by and are subject to any specific provisions of the articles of incorporation
or of law which relate to their specific subject matter, and shall also be subject to any more specific provisions, or exceptions
dealing with the same subject matter appearing elsewhere in these bylaws as amended from time to time.

 

    	 	44	 

    	 		 

    

 

WRITTEN
CONSENT IN LIEU OF MEETING OF THE 

SHAREHOLDERS
OF ONCBIOMUNE PHARMACEUTICALS, INC.

(March
__, 2017)

 

The
undersigned, being a majority of the voting power of the shareholders of ONCBIOMUNE PHARMACEUTICALS, INC., a Nevada corporation
(the “Corporation”), hereby adopt the following resolution by unanimous written consent:

 

RESOLVED,
that the undersigned shareholders hereby ratify and approve the February __, 2017 actions of the Board of Directors of the Corporation
including the amendment to Articles 4 and 8 of the Amended and Restated Articles of Incorporation and the adoption of the Amended
and Restated Bylaws as provided for aforementioned Written Consent of the Board of Directors of the Corporation.

 

IN
WITNESS WHEREOF, the undersigned being shareholders of the Corporation have executed this written consent, which may be executed
in multiple counterparts, all of which taken together shall constitute one original, the actions taken herein to be effective
as of the date first written above.

 

	Shareholder Name and Affiliation	 	Type of Stock	 	
        Shares Beneficially

        Held
	 	 	No. of Votes	 	 	
        Percent of

        Total

        Votes
	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Jonathan F. Head, Ph. D	 	Common	 	 	16,926,078	 	 	 	16,926,078	 	 	 	 	 
	 	 	Series A Preferred	 	 	500,000	 	 	 	250,000,000	 	 	 	 	 
	 	 	Series B Preferred	 	 	2,892,000	 	 	 	289,200,000	 	 	 	 	 
	Total Shares/Votes	 	 	 	 	 	 	 	 	556,126,078	 	 	 	39.40	%
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Andrew A. Kucharchuk	 	Common	 	 	5,000,000	 	 	 	5,000,000	 	 	 	0.35	%
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Banco Actinver, S.A., as Trustee of Irrevocable Trust No. 2868 under the Irrevocable Management Trust Agreement No. 2868 

  

By:____________________________ 

  

Oscar Mejia Reyes, Trust Officer 

  

By:____________________________ 

  

Gabriela Alejandra, Trust Officer	 	Common	 	 	61,158,013	 	 	 	61,158,013	 	 	 		%
	 	 	Series B Preferred	 	 	50,000,000	 	 	 	500,000,000	 	 	 	 	 
	Total Shares/Votes	 	 	 	 	 	 	 	 	561,158,013	 	 	 	39.76	%
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Total Shareholder Votes	 	 	 	 	 	 	 	 	 	 	 	 	79.51	%

 

    	 	45	 

    	 		 

    

 

CERTIFICATE
OF SECRETARY

 

ONCBIOMUNE
PHARMACEUTICALS, INC.

 

The
undersigned, Andrew A. Kucharchuk, Secretary of ONCBIOMUNE PHARMACEUTICALS, INC., a Nevada corporation (the “Company”),
does hereby certify on behalf of the Company that the Written Consents of the Board of Directors and Shareholders with an effective
date of March__, 2017 as set forth above (the “Written Consents”) are a true and correct copy of the Written Consents
adopted by the Board of Directors and Shareholders of the Company. The Written Consents have not been amended, modified or rescinded,
and remain in full force and effect as of the date hereof.

 

IN
WITNESS WHEREOF, the undersigned has executed this Certificate on this __ day of March, 2017.

 

	 	ONCBIOMUNE
    PHARMACEUTICALS, INC.
	 	 
	 	 
	 	Andrew
    A. Kucharchuk, Secretary

 

    	 	46

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}]]